| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Eckel RH | |
| Grundy SM | |||
| Zimmet PZ | |||
| P2860 | cites work | Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association | Q22241929 |
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
| Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 | ||
| Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma | Q24313050 | ||
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus | Q28168025 | ||
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
| Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets | Q28344493 | ||
| Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 | Q28366672 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey | Q29614468 | ||
| Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies | Q29614505 | ||
| Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes | Q29614548 | ||
| Global and societal implications of the diabetes epidemic | Q29614551 | ||
| Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 | ||
| Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes | Q29616567 | ||
| Mitochondrial dysfunction in the elderly: possible role in insulin resistance | Q29618783 | ||
| Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Q29619614 | ||
| The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. | Q30887060 | ||
| Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study | Q30916927 | ||
| Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. | Q44430802 | ||
| Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome | Q44538329 | ||
| Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. | Q44545460 | ||
| Insulin regulation of lipolysis in nondiabetic and IDDM subjects | Q44600986 | ||
| The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. | Q44616511 | ||
| Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome | Q44631813 | ||
| Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin | Q44647368 | ||
| Metabolic syndrome and renal sodium handling in three ethnic groups living in England | Q44656165 | ||
| Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey | Q44693873 | ||
| The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). | Q44722477 | ||
| Plasma adiponectin levels and risk of myocardial infarction in men. | Q44843420 | ||
| Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women | Q44907712 | ||
| Using metabolic syndrome traits for efficient detection of impaired glucose tolerance | Q44909555 | ||
| Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study | Q44918035 | ||
| Obesity and the metabolic syndrome in children and adolescents | Q44919660 | ||
| Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). | Q44954018 | ||
| C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study | Q44985580 | ||
| Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy | Q44990224 | ||
| C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones | Q44990813 | ||
| Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome | Q44995548 | ||
| Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans | Q45022898 | ||
| National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study | Q45027914 | ||
| Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults | Q45027927 | ||
| Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression | Q45078045 | ||
| Effects of obesity surgery on the metabolic syndrome | Q45113069 | ||
| Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease | Q47286354 | ||
| The metabolically obese, normal-weight individual revisited | Q47289395 | ||
| Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis | Q47383435 | ||
| Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery | Q47411579 | ||
| The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group | Q47690865 | ||
| Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? | Q51555185 | ||
| Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. | Q51608142 | ||
| Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. | Q53624200 | ||
| Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit? | Q53899713 | ||
| Components of the "metabolic syndrome" and incidence of type 2 diabetes. | Q53957584 | ||
| C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. | Q54002315 | ||
| Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. | Q54104864 | ||
| Regional postprandial fatty acid metabolism in different obesity phenotypes. | Q55033197 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q55921416 | ||
| High Prevalence of Insulin Resistance and Metabolic Syndrome in Overweight/Obese Preadolescent Hong Kong Chinese Children Aged 9-12 Years | Q58209915 | ||
| National Surveillance for Type 2 Diabetes Mellitus in Taiwanese Children | Q59656812 | ||
| Comment on the provisional report from the WHO consultation | Q62127032 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report | Q63694274 | ||
| Insulin resistance in essential hypertension | Q68164220 | ||
| LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow | Q71666394 | ||
| Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia | Q72769434 | ||
| The insulin resistance syndrome in smokers is related to smoking habits | Q72858524 | ||
| Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil | Q73017169 | ||
| Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome | Q73690725 | ||
| Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women | Q74506023 | ||
| Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management | Q75392143 | ||
| Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels | Q77340576 | ||
| Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density | Q77342521 | ||
| A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance | Q77652485 | ||
| Low plasma adiponectin levels predict progression of coronary artery calcification | Q81378144 | ||
| Adverse endothelial function and the insulin resistance syndrome | Q33334578 | ||
| Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels | Q33942737 | ||
| Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release | Q34185006 | ||
| Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Ph | Q34208058 | ||
| Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia | Q34236815 | ||
| Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans | Q34265631 | ||
| Adiponectin and Metabolic Syndrome | Q34269072 | ||
| Effect of thiazolidinediones on body weight in patients with diabetes mellitus | Q34284191 | ||
| Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue | Q34312182 | ||
| Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis | Q34336238 | ||
| Adipokines: inflammation and the pleiotropic role of white adipose tissue | Q34356530 | ||
| Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? | Q34361973 | ||
| Antihypertensive treatment of patients with diabetes and hypertension | Q34448154 | ||
| The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man | Q34477072 | ||
| Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
| Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. | Q34655571 | ||
| New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c | Q34682304 | ||
| AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association | Q34741065 | ||
| Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity | Q34990615 | ||
| Bariatric surgery and long-term control of morbid obesity | Q35020501 | ||
| Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle | Q35053046 | ||
| Diet composition and the metabolic syndrome: what is the optimal fat intake? | Q35059174 | ||
| Association of albuminuria and the metabolic syndrome | Q35087490 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| Insulin resistance and the sympathetic nervous system | Q35118329 | ||
| Insulin resistance and chronic cardiovascular inflammatory syndrome | Q35146311 | ||
| Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view | Q35202142 | ||
| Fatty acid metabolism and insulin secretion in pancreatic beta cells | Q35298758 | ||
| Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome | Q35546584 | ||
| Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal | Q35558879 | ||
| Lipid overload and overflow: metabolic trauma and the metabolic syndrome | Q35568995 | ||
| Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine | Q35610585 | ||
| Diabetic renal disease: from recent studies to improved clinical practice | Q35620727 | ||
| Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy | Q35641623 | ||
| Leptin effects on pancreatic beta-cell gene expression and function | Q35641742 | ||
| Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic | Q35767308 | ||
| The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation | Q35771865 | ||
| Lipodystrophies: rare disorders causing metabolic syndrome | Q35781469 | ||
| The metabolic syndrome: prevalence in worldwide populations | Q35781478 | ||
| Associations of low density lipoprotein particle composition with atherogenicity | Q35786252 | ||
| Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view | Q35840448 | ||
| Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the Ameri | Q35847314 | ||
| Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease | Q35872177 | ||
| Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships | Q35883220 | ||
| Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system | Q35933720 | ||
| Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes | Q36698641 | ||
| The metabolic syndrome and inflammation | Q37120724 | ||
| Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 | ||
| Cardiovascular morbidity and mortality associated with the metabolic syndrome | Q39513407 | ||
| The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men | Q39513420 | ||
| Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study | Q39654274 | ||
| Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans | Q40341458 | ||
| Dense low density lipoproteins and coronary artery disease | Q40598015 | ||
| C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women | Q40608305 | ||
| Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study | Q40664994 | ||
| Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension | Q40813243 | ||
| Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state | Q41053514 | ||
| Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects | Q42453208 | ||
| Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | Q42462295 | ||
| Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo | Q43555536 | ||
| Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance | Q43764679 | ||
| Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. | Q43826699 | ||
| Prevalence of impaired glucose tolerance among children and adolescents with marked obesity | Q43917576 | ||
| Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda /zeta but not on glycogen synthase kinase-3. | Q44049215 | ||
| Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial | Q44067956 | ||
| Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study | Q44081045 | ||
| Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women | Q44114894 | ||
| Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study | Q44225823 | ||
| A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids | Q44276635 | ||
| A comparison of the prevalence of the metabolic syndrome using two proposed definitions | Q44333376 | ||
| Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. | Q44404979 | ||
| P433 | issue | 9468 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 1415-28 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | The metabolic syndrome | |
| P478 | volume | 365 |
| Q43221736 | "High normal" thyroid stimulating hormone: does it matter? |
| Q34006742 | 'Red Ruby': an interactive web-based intervention for lifestyle modification on metabolic syndrome: a study protocol for a randomized controlled trial |
| Q28221639 | 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies |
| Q27677636 | (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice |
| Q53804491 | 1-Deoxynojirimycin Alleviates Insulin Resistance via Activation of Insulin Signaling PI3K/AKT Pathway in Skeletal Muscle of db/db Mice. |
| Q58896395 | 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity |
| Q80825800 | 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization |
| Q37489938 | 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents |
| Q36496258 | 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death |
| Q53353211 | 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES). |
| Q90401032 | 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome? |
| Q21245074 | A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs |
| Q47427273 | A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms). |
| Q97426338 | A Retrospective, Cross-Sectional Study on the Prevalence of Hyperuricemia Using a Japanese Healthcare Database |
| Q89578629 | A Review of Biologically Active Natural Products from Mediterranean Wild Edible Plants: Benefits in the Treatment of Obesity and Its Related Disorders |
| Q41583875 | A Single Day of Excessive Dietary Fat Intake Reduces Whole-Body Insulin Sensitivity: The Metabolic Consequence of Binge Eating. |
| Q37445670 | A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase |
| Q83466889 | A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population |
| Q33543386 | A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria |
| Q34131038 | A comparison of fat and lean body mass index to BMI for the identification of metabolic syndrome in children and adolescents. |
| Q39806728 | A comparison of the prevalence of the metabolic syndrome and its components among native Japanese and Japanese Brazilians residing in Japan and Brazil. |
| Q21284500 | A comprehensive review on metabolic syndrome |
| Q36394357 | A constellation of complications: the metabolic syndrome |
| Q37391048 | A cross-sectional study to assess any possible linkage of C/T polymorphism in CYP17A1 gene with insulin resistance in non-obese women with polycystic ovarian syndrome |
| Q35991752 | A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjects |
| Q37247153 | A disputed evidence on obesity: comparison of the effects of Rcan2(-/-) and Rps6kb1(-/-) mutations on growth and body weight in C57BL/6J mice |
| Q91976011 | A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design |
| Q34234192 | A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy |
| Q41814555 | A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart |
| Q46344079 | A hypercaloric pellet-diet cycle induces obesity and co-morbidities in Wistar rats |
| Q34505898 | A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase |
| Q35148521 | A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. |
| Q39779646 | A low arm and leg muscle mass to total body weight ratio is associated with an increased prevalence of metabolic syndrome: The Korea National Health and Nutrition Examination Survey 2010-2011. |
| Q36199043 | A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women's Health Initiative |
| Q91776028 | A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity |
| Q45899553 | A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. |
| Q36340890 | A new insight into the role of plasma fibrinogen in the development of metabolic syndrome from a prospective cohort study in urban Han Chinese population |
| Q33785757 | A new mouse model of metabolic syndrome and associated complications |
| Q38855702 | A novel Alaska pollack-derived peptide, which increases glucose uptake in skeletal muscle cells, lowers the blood glucose level in diabetic mice |
| Q90388293 | A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes |
| Q37192486 | A novel mathematical model detecting early individual changes of insulin resistance |
| Q33834810 | A novel potential biomarker for metabolic syndrome in Chinese adults: Circulating protein disulfide isomerase family A, member 4. |
| Q35852504 | A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome |
| Q44636683 | A nutrition education intervention for anthropometric and biochemical profiles of rural older Malays with metabolic syndrome. |
| Q46858371 | A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. |
| Q42997521 | A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). |
| Q88111296 | A posteriori dietary patterns and metabolic syndrome in adults: a systematic review and meta-analysis of observational studies |
| Q35107146 | A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. |
| Q35060176 | A randomized cross-over trial of the postprandial effects of three different diets in patients with type 2 diabetes |
| Q51371225 | A randomized double-blind placebo-controlled study of Pu'er tea extract on the regulation of metabolic syndrome. |
| Q47280336 | A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women |
| Q51352144 | A randomized trial of protein supplementation compared with extra fast food on the effects of resistance training to increase metabolism. |
| Q28076622 | A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients |
| Q34400551 | A review of efficacious technology-based weight-loss interventions: five key components |
| Q36970039 | A simple scoring method using cardiometabolic risk measurements in pregnancy to determine 10-year risk of type 2 diabetes in women with gestational diabetes |
| Q35827840 | A six question screen to facilitate primary cardiovascular disease prevention |
| Q26776259 | A systematic review on the association of serum selenium and metabolic syndrome |
| Q42966181 | A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes |
| Q36174272 | ACE Reduces Metabolic Abnormalities in a High-Fat Diet Mouse Model |
| Q35670860 | AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages |
| Q37864217 | AMP-activated protein kinase and metabolic control |
| Q33783499 | AMPK and SIRT1: a long-standing partnership? |
| Q51464229 | APOA5 variants and metabolic syndrome in Caucasians. |
| Q28743272 | APOE genotype and cardio-respiratory fitness interact to determine adiposity in 8-year-old children from the Tasmanian Infant Health Survey |
| Q57825533 | Abdominal obesity and cardiometabolic risk in children and adolescents, are we aware of their relevance? |
| Q36682671 | Abdominal obesity and metabolic syndrome |
| Q44362164 | Abdominal obesity is associated with cardiovascular risk in Japanese children and adolescents. |
| Q90461400 | Abdominal obesity, metabolic dysfunction, and metabolic syndrome in U.S. adolescents: National Health and Nutrition Examination Survey 2011-2016 |
| Q37304801 | Abnormal cardiac structure and function in the metabolic syndrome: a population-based study |
| Q37683744 | Abnormal cation exchange in insulin-resistant patients with essential hypertension |
| Q44609893 | Acculturation factors and metabolic syndrome among Japanese-Brazilian men in Japan: a cross-sectional descriptive study |
| Q57030406 | Achacha () Rind Improves Cardiovascular Function in Rats with Diet-Induced Metabolic Syndrome |
| Q51609733 | Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. |
| Q35721251 | Acute and subchronic in-vivo effects of Ferula hermonis L. and Sambucus nigra L. and their potential active isolates in a diabetic mouse model of neuropathic pain |
| Q35017415 | Acute chest syndrome in severity of sickle cell diseases |
| Q34016466 | Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney |
| Q36591957 | Acute knockdown of the insulin receptor or its substrates Irs1 and 2 in 3T3-L1 adipocytes suppresses adiponectin production |
| Q35846348 | Adherence and Attrition in a Web-Based Lifestyle Intervention for People with Metabolic Syndrome |
| Q79520934 | Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway |
| Q30357655 | Adipocytokines in obesity and metabolic disease. |
| Q26865268 | Adipokines, metabolic syndrome and rheumatic diseases |
| Q39175599 | Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity |
| Q38901727 | Adiponectin and metabolic syndrome in a Tunisian population |
| Q43268922 | Adiponectin gene single-nucleotide polymorphisms and treatment response to obesity. |
| Q59315861 | Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome |
| Q92158206 | Adiponectin: An Indicator for Metabolic Syndrome |
| Q39759797 | Adipophilin protein expression in muscle--a possible protective role against insulin resistance |
| Q51464766 | Adipose tissue and liver lipid metabolism in obese children: role of the body mass index and the presence of acanthosis nigricans. |
| Q28080748 | Adipose tissue dysfunction and its effects on tumor metabolism |
| Q33752824 | Adipose tissue dysfunction as a central mechanism leading to dysmetabolic obesity triggered by chronic exposure to p,p'-DDE. |
| Q27026065 | Adipose tissue dysfunction in nascent metabolic syndrome |
| Q35497928 | Adipose tissue dysregulation in patients with metabolic syndrome |
| Q46574444 | Adipose tissue fatty acid metabolism in insulin-resistant men. |
| Q36824635 | Adiposity has differing associations with incident coronary heart disease and mortality in the Scottish population: cross-sectional surveys with follow-up |
| Q51246676 | Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS. |
| Q37119337 | Adrenal steroids and the metabolic syndrome |
| Q36576284 | Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers |
| Q31114345 | Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial |
| Q35550059 | Age and metabolic risk factors associated with oxidatively damaged DNA in human peripheral blood mononuclear cells. |
| Q37957749 | Age-related cardiovascular disease and the beneficial effects of calorie restriction |
| Q39789971 | Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder. |
| Q33295439 | Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study |
| Q37345111 | Aging attenuates the association of central obesity with the accumulation of metabolic risk factors when assessed using the waist circumference measured at the umbilical level (the Japanese standard method). |
| Q36592331 | Aging promotes the development of diet-induced murine steatohepatitis but not steatosis |
| Q33454936 | Aging, female sex, migration, elevated HDL-C, and inflammation are associated with prevalence of metabolic syndrome among African bank employees |
| Q26828819 | Alanine aminotransferase-old biomarker and new concept: a review |
| Q36402904 | Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults |
| Q27000153 | Alcoholic and non-alcoholic steatohepatitis |
| Q64273133 | Alleviates Insulin Resistance in Diet-Induced Obese Mice by Modulating Inflammation |
| Q36736338 | Alpha-lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome |
| Q48550804 | Alterations in gut microbiota associated with a cafeteria diet and the physiological consequences in the host. |
| Q36625116 | Alterations in lipoprotein defense against oxidative stress in metabolic syndrome |
| Q46290681 | Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome. |
| Q39791849 | Altered distribution of caveolin-1 in early liver steatosis. |
| Q27438116 | Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice |
| Q35131396 | Altered fetal skeletal muscle nutrient metabolism following an adverse in utero environment and the modulation of later life insulin sensitivity. |
| Q38651646 | Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis. |
| Q33304235 | Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis |
| Q39358990 | An Obesity Paradox: Increased Body Mass Index Is Associated with Decreased Aortic Atherosclerosis |
| Q36348575 | An exploratory analysis of dynamic change of metabolic syndrome in relation to the risk of developing cardiovascular disease in a chinese cohort |
| Q42797721 | An in vitro study reveals the nutraceutical potential of punicic acid relevant to diabetes via enhanced GLUT4 expression and adiponectin secretion |
| Q51367456 | An integrative view on the carotid artery alterations in metabolic syndrome. |
| Q37634761 | An interactive web-based intervention on nutritional status, physical activity and health-related quality of life in patient with metabolic syndrome: a randomized-controlled trial (The Red Ruby Study). |
| Q51328269 | An oral mixed fat load is followed by a modest anti-inflammatory adipocytokine response in overweight patients with metabolic syndrome. |
| Q46527877 | An update of the general health status in the indigenous populations of Malaysia |
| Q92860250 | Analysis of 1508 Plasma Samples by Capillary-Flow Data-Independent Acquisition Profiles Proteomics of Weight Loss and Maintenance |
| Q28392948 | Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study |
| Q39255753 | Analysis of multiple related phenotypes in genome-wide association studies |
| Q90279299 | Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery |
| Q37990639 | Androgen deprivation therapy for prostate cancer: implications for cardiometabolic clinical care |
| Q46470125 | Androgen receptor gene CAG repeat length in women with metabolic syndrome |
| Q34505196 | Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology |
| Q55192988 | Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. |
| Q27303704 | Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin Resistance |
| Q35825616 | Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men |
| Q84378924 | Angiotensin II receptor blockers and insulin resistance |
| Q51928703 | Anthropometric evaluations of body composition of undergraduate students at the University of La Reunion. |
| Q39802865 | Anthropometric predictors for the risk of chronic disease in non-diabetic, non-hypertensive young Mexican women |
| Q28740744 | Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived body composition and can be used to screen for diabetes |
| Q90230220 | Anti-Metabolic Syndrome Effects of Fucoidan from Fucus vesiculosus via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling |
| Q47106512 | Anti-adipogenic effects of the traditional herbal formula Dohongsamul-tang in 3T3-L1 adipocytes |
| Q34368361 | Anti-hyperglycemic and anti-hyperlipidemic potential of a polyherbal preparation "Diabegon" in metabolic syndrome subject with type 2 diabetes |
| Q53665474 | Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats. |
| Q90580717 | Anti-obesity effects of α-cyclodextrin-stabilized 4-methylthio-3-butenyl isothiocyanate from daikon (Raphanus sativus var. longipinnatus) in mice |
| Q28069630 | Antidiabetic Properties, Bioactive Constituents, and Other Therapeutic Effects of Scoparia dulcis |
| Q57490130 | Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome |
| Q36415349 | Antihypertensive medications and blood sugar: theories and implications |
| Q91896482 | Antimetabolic Syndrome Effect of Phytosome Containing the Combined Extracts of Mulberry and Ginger in an Animal Model of Metabolic Syndrome |
| Q47355158 | Antimicrobial Emulsifier-Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low-Grade Inflammation in Low-Fat Diet Fed Mice |
| Q40105268 | Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism |
| Q39805075 | Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome |
| Q46961767 | Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome |
| Q35668013 | Apple Peel Supplemented Diet Reduces Parameters of Metabolic Syndrome and Atherogenic Progression in ApoE-/- Mice. |
| Q64900258 | Application of ELISA Technique and Human Microsomes in the Search for 11β-Hydroxysteroid Dehydrogenase Inhibitors. |
| Q55005999 | Approach to the Treatement of Metabolic Syndrome. |
| Q30396493 | Appropriate waist circumference cut points for identifying insulin resistance in black youth: a cross sectional analysis of the 1986 Jamaica birth cohort |
| Q36632105 | Appropriate waist circumference cutoff values for persons with multiple cardiovascular risk factors in Japan: a large cross-sectional study |
| Q35079321 | Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control |
| Q48140447 | Are Perceived and Objective Distances to Fresh Food and Physical Activity Resources Associated with Cardiometabolic Risk? |
| Q44777050 | Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey |
| Q57242484 | Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome? |
| Q35084824 | Area-level socioeconomic characteristics, prevalence and trajectories of cardiometabolic risk |
| Q36874131 | Areca nut chewing and metabolic syndrome: evidence of a harmful relationship. |
| Q36966329 | Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome. |
| Q36522670 | Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp rat |
| Q37764043 | Ascorbate improves metabolic abnormalities in Wrn mutant mice but not the free radical scavenger catechin |
| Q33832143 | Assessment of Insulin Sensitivity and its Convalescence with Dietary Rehabilitation in Undernourished Rural West Bengal Population |
| Q46435307 | Assessment of serum leptin, insulin resistance and metabolic syndrome in patients with skin tags. |
| Q56988177 | Association Among Rheumatoid Arthritis, Oral Hygiene, and Periodontitis |
| Q36822281 | Association Between Estimated 24-h Urinary Sodium Excretion and Metabolic Syndrome in Korean Adults: The 2009 to 2011 Korea National Health and Nutrition Examination Survey. |
| Q47584722 | Association Between Socioeconomic Determinants and the Metabolic Syndrome in the German Health Interview and Examination Survey for Adults (DEGS1) - A Mediation Analysis. |
| Q36088721 | Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations |
| Q55435518 | Association between Bone Mineral Density and Albuminuria: Cross-Sectional Analysis of Data from the 2011 Korea National Health and Nutrition Examination Survey V-2. |
| Q44066171 | Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia. |
| Q36183112 | Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats |
| Q92823767 | Association between Periodontitis and Metabolic Syndrome in a Korean Nationally Representative Sample of Adults Aged 35-79 Years |
| Q64898704 | Association between Physical Fitness and Cardiometabolic Risk of Children and Adolescents in Korea. |
| Q57213916 | Association between Serum Liver Enzymes and Metabolic Syndrome in Korean Adults |
| Q36648197 | Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran |
| Q43058765 | Association between adiponectin and metabolic syndrome in older adults from major cities of China. |
| Q33665153 | Association between chronic periodontal disease and obesity: a systematic review and meta-analysis |
| Q58782220 | Association between insulin resistance and the development of cardiovascular disease |
| Q34499775 | Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study |
| Q35054630 | Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study |
| Q35088955 | Association between metabolic syndrome and bone fractures: a meta-analysis of observational studies |
| Q89519934 | Association between metabolic syndrome and prognosis of breast cancer: a meta-analysis of follow-up studies |
| Q46981314 | Association between metabolic syndrome, diabetes mellitus and prostate cancer risk |
| Q51307384 | Association between osteocalcin and metabolic syndrome in postmenopausal women. |
| Q30856824 | Association between prevalence of hypertension and components of metabolic syndrome: the data from Kailuan community |
| Q35289060 | Association between retinal artery lesions and nonalcoholic fatty liver disease |
| Q43295721 | Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis |
| Q88551429 | Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders |
| Q50601108 | Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia. |
| Q42276378 | Association between single nucleotide polymorphism rs9534275 and the risk of coronary artery disease and ischemic stroke |
| Q50662671 | Association between testosterone levels and the metabolic syndrome in adult men. |
| Q33311602 | Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample |
| Q36509443 | Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample |
| Q53976347 | Association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and erectile dysfunction in patients with metabolic syndrome. |
| Q37432991 | Association between uterine leiomyoma and metabolic syndrome in parous premenopausal women: A case-control study |
| Q91976118 | Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function |
| Q89431545 | Association of High-Risk Drinking with Metabolic Syndrome and Its Components in Elderly Korean Men: The Korean National Health and Nutrition Examination Survey 2010-2012 |
| Q35851654 | Association of Inflammation with Metabolic Syndrome among Low-Income Rural Kazakh and Uyghur Adults in Far Western China |
| Q35932334 | Association of Metabolic Syndrome with the Cardioankle Vascular Index in Asymptomatic Korean Population. |
| Q57476343 | Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women |
| Q40156799 | Association of Resistance Exercise, Independent of and Combined With Aerobic Exercise, With the Incidence of Metabolic Syndrome. |
| Q91576387 | Association of Serum Uric Acid with cardio-metabolic risk factors and metabolic syndrome in seafarers working on tankers |
| Q36383361 | Association of adiponectin and metabolic syndrome in adolescents: the caspian- III study |
| Q36212090 | Association of adiponectin and metabolic syndrome in women |
| Q36635572 | Association of apolipoprotein A5 gene -1131T>C polymorphism with the risk of metabolic syndrome in Korean subjects |
| Q35006764 | Association of blood pressure with development of metabolic syndrome components: a five-year Retrospective Cohort study in Beijing |
| Q37696905 | Association of body mass index, waist circumference, and metabolic syndrome with serum cystatin C in a Chinese population |
| Q37157870 | Association of chronic periodontitis with metabolic syndrome: A cross-sectional study |
| Q36073635 | Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study |
| Q34169969 | Association of dietary vitamin D, serum 25-hydroxyvitamin D, insulin-like growth factor-1 concentrations and components of metabolic syndrome among Iranian women |
| Q37149120 | Association of gene polymorphism of the fat mass and obesity associated gene with metabolic syndrome: a retrospective cohort study in Japanese workers |
| Q34672241 | Association of genetic variants in the adiponectin gene with metabolic syndrome: a case-control study and a systematic meta-analysis in the Chinese population |
| Q34479203 | Association of inflammatory and oxidative stress markers with metabolic syndrome in asian indians in India |
| Q36091431 | Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes |
| Q49060418 | Association of low vitamin D levels with metabolic syndrome in hemodialysis patients. |
| Q34948104 | Association of metabolic syndrome with coronary artery calcification |
| Q37130005 | Association of metabolic syndrome with serum fibroblast growth factor 21 in kidney transplanted patients |
| Q34229069 | Association of metabolic syndrome with severity of coronary artery disease |
| Q58307131 | Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease |
| Q34722566 | Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects |
| Q41116375 | Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy |
| Q36830511 | Association of racial disparities in the prevalence of insulin resistance with racial disparities in vitamin D levels: National Health and Nutrition Examination Survey (2001-2006) |
| Q36986429 | Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: In vitro and in vivo evidence |
| Q36426703 | Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study |
| Q35870961 | Association of serum hepatocyte growth factor with pericardial fat volume in patients with coronary artery disease. |
| Q49630270 | Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver. |
| Q37051894 | Association of socioeconomic status measured by education and risk factors for carotid atherosclerosis: cross-sectional study |
| Q43271915 | Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. |
| Q46498426 | Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus |
| Q45398617 | Association of uric acid with obesity and endothelial dysfunction in children and early adolescents |
| Q33612532 | Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance |
| Q48892922 | Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population. |
| Q47278784 | Associations between long-term physical activity, waist circumference and weight gain: a 30-year longitudinal twin study. |
| Q28389299 | Associations between resident perceptions of the local residential environment and metabolic syndrome |
| Q41592634 | Associations between the number of natural teeth and metabolic syndrome in adults |
| Q34785895 | Associations of cardiorespiratory fitness, physical activity, and obesity with metabolic syndrome in Hong Kong Chinese midlife women |
| Q40744961 | Associations of exercise, sedentary time and insomnia with metabolic syndrome in Taiwanese older adults: A 1-year follow-up study |
| Q57135001 | Associations of immunometabolic risk factors with symptoms of depression and anxiety: The role of cardiac vagal activity |
| Q36117861 | Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? |
| Q60696865 | Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: a prospective cohort study |
| Q37610597 | Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population |
| Q34611738 | Asymptomatic intracranial arterial stenosis and metabolic syndrome: the APAC study |
| Q50863344 | Atherogenic dyslipidaemic profiles associated with the development of Type 2 diabetes: a 3.1-year longitudinal study. |
| Q38793819 | Atherosclerosis and vasomotor dysfunction in arteries of animals after exposure to combustion-derived particulate matter or nanomaterials |
| Q92069888 | Atypical antipsychotic monitoring: A survey of patient knowledge and experience |
| Q46045634 | Autonomic modulation in patients with congenital generalized lipodystrophy (Berardinelli-Seip syndrome). |
| Q33840453 | Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications |
| Q89518379 | Autophagy in metabolic syndrome: breaking the wheel by targeting the renin-angiotensin system |
| Q40205269 | Autosplenectomy in severity of sickle cell diseases |
| Q90048530 | B Lymphocytes and Adipose Tissue Inflammation |
| Q45997350 | B-type natriuretic peptide levels and insulin resistance in patients with severe ischemic myocardial dysfunction. |
| Q36588694 | Background and treatment of metabolic syndrome: a therapeutic challenge |
| Q64886755 | Bariatric Surgery in Rats Upregulates FSP27 Expression in Fat Tissue to Affect Fat Hydrolysis and Metabolism. |
| Q97518245 | Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Jinlida Granules on Metabolic Syndrome in Patients With Abnormal Glucose Metabolism |
| Q37825382 | Behavioural interventions for obese adults with additional risk factors for morbidity: systematic review of effects on behaviour, weight and disease risk factors. |
| Q64115420 | Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives |
| Q26752844 | Beneficial Effects of Dietary Nitrate on Endothelial Function and Blood Pressure Levels |
| Q43263183 | Beneficial effects of telmisartan in an HIV+ diabetic insulin-dependent patient |
| Q35846030 | Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients |
| Q28507193 | Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment |
| Q42492048 | Betel nut extract and arecoline block insulin signaling and lipid storage in 3T3-L1 adipocytes. |
| Q36478127 | Bidirectional Relationship Between Diabetes and Acute Pancreatitis: A Population-Based Cohort Study in Taiwan |
| Q35898326 | Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies |
| Q94601843 | Bidirectional association between metabolic syndrome and osteoarthritis: a meta-analysis of observational studies |
| Q90091467 | Bifidobacterium animalis subsp. lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43 |
| Q35762725 | Bifidogenic effect of grain larvae extract on serum lipid, glucose and intestinal microflora in rats |
| Q43870640 | Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). |
| Q36263135 | Biochemical and genetic studies on cardiometabolic syndrome |
| Q35170014 | Bioelectrical impedance outperforms waist circumference for predicting cardiometabolic risk in Congolese hypertensive subjects: a cross-sectional study. |
| Q37686246 | Bioenergetic medicine |
| Q38018900 | Biology of metabolic syndrome in a vascular patient |
| Q37328339 | Biomarkers of the metabolic syndrome and breast cancer prognosis. |
| Q50483428 | Bisphenol-A and metabolic diseases: epigenetic, developmental and transgenerational basis. |
| Q55265787 | Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial. |
| Q51393328 | Blood glucose monitoring in the normal population: the PREDICA study. |
| Q37280274 | Body Mass Index and Obesity : Tailoring "cut-off" for an Asian Indian Male Population. |
| Q35853444 | Body adiposity indices are associated with hypertension in a black, urban Free State community |
| Q35191556 | Body fat accumulation in zebrafish is induced by a diet rich in fat and reduced by supplementation with green tea extract |
| Q50656852 | Body fat indices for identifying risk of hypertension in Indian children. |
| Q36714310 | Body mass growth in common marmosets: toward a model of pediatric obesity |
| Q51789601 | Body mass index among Japanese inpatients with schizophrenia. |
| Q43506008 | Body mass index of inpatients with schizophrenia in Japan |
| Q34352621 | Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women |
| Q47318650 | Body weight and weight change in relation to blood pressure in normotensive men. |
| Q55549178 | Book Review: Rongioletti F, Smoller BR (eds.). Clinical and Pathological Aspects of Skin Diseases in Endocrine, Metabolic, Nutritional and Deposition Disease. New York: Springer; 2010. |
| Q47148642 | Breaking down, starting up: can a vitamin C-enriched gelatin supplement before exercise increase collagen synthesis? |
| Q33715393 | Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle |
| Q61684825 | C-reactive protein and metabolic syndrome in women with previous gestational diabetes |
| Q46689847 | C-reactive protein and metabolic syndrome in youth: a strong relationship? |
| Q36911487 | C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery |
| Q80825814 | C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome |
| Q49379954 | CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis. |
| Q34680490 | CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY. |
| Q34847373 | COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats. |
| Q90450986 | CRISPR/Cas9-mediated Angptl8 knockout suppresses plasma triglyceride concentrations and adiposity in rats |
| Q58576951 | Cafeteria Diet Feeding in Young Rats Leads to Hepatic Steatosis and Increased Gluconeogenesis under Fatty Acids and Glucagon Influence |
| Q42796833 | Calcium oxalate crystal deposition in metabolic syndrome model rat kidneys |
| Q38087380 | Calculating cardiac risk in obese adolescents before and after onset of lifestyle intervention |
| Q35228167 | Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)? |
| Q37623972 | Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome |
| Q37210036 | Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome |
| Q21245077 | Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction |
| Q50290643 | Cardiac Development and Transcription Factors: Insulin Signalling, Insulin Resistance, and Intrauterine Nutritional Programming of Cardiovascular Disease. |
| Q35504243 | Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation |
| Q35071304 | Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor |
| Q26827207 | Cardiac remodeling in obesity |
| Q53235672 | Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome. |
| Q43199720 | Cardiorespiratory fitness and components of the metabolic syndrome in sedentary men. |
| Q33930226 | Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content |
| Q36331223 | Cardiorespiratory fitness, alcohol intake, and metabolic syndrome incidence in men. |
| Q36088468 | Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes |
| Q33582266 | Cardiovascular consequences of obese and nonobese obstructive sleep apnea |
| Q38076030 | Cardiovascular disease in childhood: the role of obesity |
| Q103740196 | Cardiovascular disease in patients with type 1 diabetes: early evaluation, risk factors and possible relation with cardiac autoimmunity |
| Q45014583 | Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model |
| Q36679594 | Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents |
| Q37827183 | Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency. |
| Q28074308 | Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study |
| Q51877973 | Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. |
| Q42910506 | Cardiovascular risk factors and immunosuppressive regimen after liver transplantation. |
| Q45012820 | Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM). |
| Q43067231 | Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy |
| Q49645824 | Cardiovascular risk of adipokines: a review. |
| Q33712412 | Cardiovascular risk profile: cross-sectional analysis of motivational determinants, physical fitness and physical activity |
| Q61962599 | Casual serum triglyceride as a predictor of premature type 2 diabetes mellitus: an 8-year cohort study of middle-aged Japanese workers |
| Q97643708 | Catecholamines suppress fatty acid re-esterification and increase oxidation in white adipocytes via STAT3 |
| Q90215839 | Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome |
| Q35019983 | Central adiposity is negatively associated with hippocampal-dependent relational memory among overweight and obese children |
| Q46215877 | Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms |
| Q41791619 | Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders |
| Q91896859 | Cerebroprotective Effect against Cerebral Ischemia of the Combined Extract of Oryza sativa and Anethum graveolens in Metabolic Syndrome Rats |
| Q36572295 | Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study |
| Q81305727 | Change in serum uric acid between baseline and 1-year follow-up and its associated factors in male subjects |
| Q90668590 | Changes in Plasma Protein Expression Indicative of Early Diet-induced Metabolic Disease in Male Pigs (Sus scrofa) |
| Q39773587 | Changing physician practice behavior to measure and improve clinical outcomes |
| Q90441744 | Characteristics of pulmonary infection after mitral valve repair in patients with metabolic syndrome and its relationship with blood pressure, blood glucose and blood lipid |
| Q37296584 | Characterization of obese phenotypes in a small nonhuman primate, the common marmoset (Callithrix jacchus) |
| Q38597927 | Childhood Age and Associations Between Childhood Metabolic Syndrome and Adult Risk for Metabolic Syndrome, Type 2 Diabetes Mellitus and Carotid Intima Media Thickness: The International Childhood Cardiovascular Cohort Consortium. |
| Q34939164 | Childhood obesity and cardiovascular disease: links and prevention strategies |
| Q42322521 | Childhood obesity and obstructive sleep apnea |
| Q35663966 | Childhood obesity and risk of the adult metabolic syndrome: a systematic review |
| Q86271255 | Childhood obesity, metabolic syndrome and Pentraxin-3 |
| Q37337732 | Childhood predictors of the metabolic syndrome in middle-aged adults: the Muscatine study |
| Q44426405 | Childhood underweight, weight gain during childhood to adolescence/young adulthood and incidence of adult metabolic syndrome in the SUN (Seguimiento Universidad de Navarra) Project |
| Q36537711 | Cholesterol gallstone disease. |
| Q64071917 | Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities |
| Q36902536 | Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization |
| Q36910609 | Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice |
| Q28681239 | Chronic carbon monoxide treatment attenuates development of obesity and remodels adipocytes in mice fed a high-fat diet |
| Q35555547 | Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma |
| Q46330368 | Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats. |
| Q34035348 | Chronic inflammation in obesity and the metabolic syndrome |
| Q46252912 | Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats |
| Q35138545 | Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys |
| Q37570870 | Cinnamon effects on metabolic syndrome: a review based on its mechanisms |
| Q92186966 | Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women |
| Q36549866 | Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome |
| Q36780368 | Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. |
| Q64965860 | Circulating exosomes deliver free fatty acids from the bloodstream to cardiac cells: Possible role of CD36. |
| Q64118176 | Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers |
| Q36087928 | Circulatory syndrome: an evolution of the metabolic syndrome concept! |
| Q91651350 | Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome |
| Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
| Q88068575 | Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran |
| Q43749603 | Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant |
| Q43205612 | Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context. |
| Q53974217 | Clustered Cardiovascular Risk Factors Are Associated with Inflammatory Markers in Adolescents. |
| Q92025378 | Clustering Effects of Metabolic Factors and the Risk of Metabolic Syndrome |
| Q37640527 | Clustering and combining pattern of metabolic syndrome components among Iranian population with latent class analysis |
| Q46955650 | Clustering and combining pattern of metabolic syndrome components in a rural Brazilian adult population |
| Q64112238 | Clustering of Metabolic Risk Components and Associated Lifestyle Factors: A Nationwide Adolescent Study in Taiwan |
| Q38051841 | Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge |
| Q34181391 | Coexpression network analysis in abdominal and gluteal adipose tissue reveals regulatory genetic loci for metabolic syndrome and related phenotypes |
| Q37061183 | Cognition and diabetes: a lifespan perspective. |
| Q88314734 | Cohort study to determine the waist circumference cutoffs for predicting type 2 diabetes mellitus in rural China |
| Q34361855 | Combinational risk factors of metabolic syndrome identified by fuzzy neural network analysis of health-check data |
| Q28658187 | Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study |
| Q44543493 | Common Variations in Perilipin rs1052700 and FTO rs3751812 Gene Variants, and Risk for Obesity and Type-2 Diabetes |
| Q79262021 | Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study |
| Q28278747 | Common genetic variation near MC4R is associated with waist circumference and insulin resistance |
| Q24621500 | Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI |
| Q37231746 | Community-based study on CKD subjects and the associated risk factors |
| Q51499612 | Community-based study on summer-winter differences of component of metabolic syndrome in Kinmen, Taiwan. |
| Q92715875 | Comparative Abilities of Fasting Plasma Glucose and Haemoglobin A1c in Predicting Metabolic Syndrome among Apparently Healthy Normoglycemic Ghanaian Adults |
| Q58602651 | Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang |
| Q37652064 | Comparison between cafeteria and high-fat diets in the induction of metabolic dysfunction in mice |
| Q89424972 | Comparison between different criteria for metabolic syndrome in schoolchildren from southern Brazil |
| Q36325949 | Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans |
| Q43996934 | Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls |
| Q36121477 | Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach |
| Q92816345 | Comparison of the Serum Metabolic Fingerprint of Different Exercise Modes in Men with and without Metabolic Syndrome |
| Q37085260 | Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients |
| Q36512836 | Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function |
| Q92966600 | Components and Risk Factors of Metabolic Syndrome among Rural Nigerian Workers |
| Q28385239 | Components of Metabolic Syndrome as Risk Factors for Hearing Threshold Shifts. |
| Q52727487 | Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older. |
| Q51467442 | Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia. |
| Q35049462 | Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome |
| Q37291503 | Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population |
| Q90679916 | Conceptualization of a Parasympathetic Endocrine System |
| Q36084615 | Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance |
| Q58419706 | Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica |
| Q36807686 | Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. |
| Q37815485 | Consequences of physical inactivity in chronic obstructive pulmonary disease. |
| Q47716824 | Consumption of coffee or caffeine and serum concentration of inflammatory markers: A systematic review. |
| Q33702700 | Consumption of sugar-sweetened beverages is associated with components of the metabolic syndrome in adolescents |
| Q43176368 | Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity |
| Q37575442 | Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. |
| Q28194400 | Controversies in stable coronary artery disease |
| Q38769110 | Convertible visceral fat as a therapeutic target to curb obesity. |
| Q35995551 | Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. |
| Q37651021 | Correlation between Body Mass Index and Waist Circumference in Patients with Metabolic Syndrome |
| Q47099734 | Correlation between Insulin Resistance and Thyroid Nodule in Type 2 Diabetes Mellitus. |
| Q57488619 | Correlation between normal range of serum alanine aminotransferase level and metabolic syndrome: A community-based study |
| Q35885619 | Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up |
| Q37607386 | Cryptotanshinone Regulates Androgen Synthesis through the ERK/c-Fos/CYP17 Pathway in Porcine Granulosa Cells |
| Q51379866 | Cumulative risk of cardiovascular events after orthotopic liver transplantation. |
| Q46682082 | Curative diet supplementation with a melon superoxide dismutase reduces adipose tissue in obese hamsters by improving insulin sensitivity |
| Q36651330 | Current thoughts on maternal nutrition and fetal programming of the metabolic syndrome |
| Q36829866 | Current views on genetics and epigenetics of cholesterol gallstone disease |
| Q35180007 | Cyanidin-3-O-β-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARγ activity in human omental adipocytes. |
| Q34691844 | Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese zucker rat mesenteric arteries |
| Q41728191 | Cytokine and growth factor profiling in patients with the metabolic syndrome. |
| Q90452412 | Cytokine, Chemokine, and Cytokine Receptor Changes Are Associated With Metabolic Improvements After Bariatric Surgery |
| Q34873891 | DNAJB3/HSP-40 cochaperone is downregulated in obese humans and is restored by physical exercise |
| Q58698509 | Daily intake of extract decreases abdominal fat in overweight and preobese subjects: a randomized, double-blind, placebo-controlled clinical study |
| Q40288139 | Dairy Consumption Lowers Systemic Inflammation and Liver Enzymes in Typically Low-Dairy Consumers with Clinical Characteristics of Metabolic Syndrome |
| Q41603899 | Declined plasma sfrp5 concentration in patients with type 2 diabetes and latent autoimmune diabetes in adults |
| Q46643026 | Decorin is a secreted protein associated with obesity and type 2 diabetes. |
| Q35067845 | Deficiency in clonogenic endometrial mesenchymal stem cells in obese women with reproductive failure--a pilot study |
| Q31139035 | Defining a Contemporary Ischemic Heart Disease Genetic Risk Profile Using Historical Data |
| Q36251554 | Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease |
| Q26780349 | Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis |
| Q37052593 | Depressive symptoms and metabolic syndrome: is inflammation the underlying link? |
| Q46021155 | Depressive symptoms and metabolic syndrome: selective association in older women. |
| Q35195107 | Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study |
| Q90288178 | Depressive symptoms, perceived stress, and metabolic health: The REGARDS study |
| Q33493414 | Deregulation of hepatic insulin sensitivity induced by central lipid infusion in rats is mediated by nitric oxide |
| Q34401940 | Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model |
| Q36317324 | Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe me |
| Q101574176 | Determinant components of newly onset versus improved metabolic syndrome in a population of Iran |
| Q38831680 | Determinants for clinical events in gallstone carriers unaware of their gallstones |
| Q55361099 | Determinants of Crystalluria among Type 2 Diabetes Patients; A Case-Control Study of the Agona West Municipality, Ghana. |
| Q37208013 | Development and application of specific cytokine assays in tissue samples from a bottlenose dolphin with hyperinsulinemia |
| Q33719151 | Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit. |
| Q47184635 | Development and validation of a Food Choices Score for use in weight-loss interventions |
| Q33581560 | Development of a sleeve gastrectomy weight loss model in obese Zucker rats |
| Q55294006 | Developmental origins of metabolic disorders: The need for biomarker candidates and therapeutic targets from adequate preclinical models. |
| Q35857205 | Diabetes and hypertension: is there a common metabolic pathway? |
| Q45213357 | Diabetes and nephrolithiasis |
| Q51895077 | Diabetes and overweight associate with non-APOE4 genotype in an Alzheimer's disease population. |
| Q38248610 | Diabetes and the brain: oxidative stress, inflammation, and autophagy |
| Q44489652 | Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study |
| Q37119373 | Diabetes mellitus, insulin resistance, hyperglycemia, and stroke |
| Q37984922 | Diabetes, hyperglycaemia, and acute ischaemic stroke |
| Q37319716 | Diabetic dyslipidemia and cardiovascular risk |
| Q28192856 | Diagnosis and management of the metabolic syndrome in obesity |
| Q49632470 | Diagnostic imaging in the management of patients with metabolic syndrome. |
| Q46816080 | Diet-induced central obesity and insulin resistance in rabbits |
| Q37300616 | Diet-induced metabolic disturbances as modulators of brain homeostasis |
| Q35092364 | Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. |
| Q89804498 | Dietary Behaviors and Metabolic Syndrome in Schizophrenia Patients |
| Q47248488 | Dietary Fiber and Metabolic Syndrome: A Meta-Analysis and Review of Related Mechanisms. |
| Q41203643 | Dietary Glycemic Index and Glycemic Load Are Positively Associated with Risk of Developing Metabolic Syndrome in Middle-Aged and Elderly Adults. |
| Q35916925 | Dietary Very Long Chain Saturated Fatty Acids and Metabolic Factors: Findings from the Korea National Health and Nutrition Examination Survey 2013. |
| Q37019058 | Dietary approaches that delay age-related diseases |
| Q37194439 | Dietary beta-tocopherol and linoleic acid, serum insulin, and waist circumference predict circulating sex hormone-binding globulin in premenopausal women |
| Q40018926 | Dietary consumption of advanced glycation end products and risk of metabolic syndrome |
| Q36084881 | Dietary factors and biomarkers of systemic inflammation in older people: the Lothian Birth Cohort 1936. |
| Q46798142 | Dietary factors and metabolic syndrome |
| Q34199764 | Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice |
| Q26801360 | Dietary inorganic nitrate: From villain to hero in metabolic disease? |
| Q33911842 | Dietary lipid content reorganizes gut microbiota and probiotic L. rhamnosus attenuates obesity and enhances catabolic hormonal milieu in zebrafish. |
| Q38169805 | Dietary modulation of the inflammatory cascade |
| Q57069391 | Dietary n-3 long-chain polyunsaturated fatty acids upregulate energy dissipating metabolic pathways conveying anti-obesogenic effects in mice |
| Q35001300 | Dietary triglycerides act on mesolimbic structures to regulate the rewarding and motivational aspects of feeding. |
| Q36470299 | Differences in Expression, Content, and Activity of 11β-HSD1 in Adipose Tissue between Obese Men and Women |
| Q35814763 | Differences in physical activity domains, guideline adherence, and weight history between metabolically healthy and metabolically abnormal obese adults: a cross-sectional study |
| Q89598771 | Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects |
| Q36610550 | Different impacts of metabolic syndrome components on insulin resistance in type 2 diabetes |
| Q41888201 | Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes |
| Q42287113 | Differential Tissue-specific and Pathway-specific Anti-obesity Effects of Green Tea and Taeumjowitang, a Traditional Korean Medicine, in Mice |
| Q47143257 | Differential associations of metabolic risk factors on cortical thickness in metabolic syndrome |
| Q37173374 | Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice |
| Q37025055 | Differential impact of dilator stimuli on increased myogenic activation of cerebral and skeletal muscle resistance arterioles in obese zucker rats |
| Q44831942 | Differential methylation in visceral adipose tissue of obese men discordant for metabolic disturbances |
| Q35072544 | Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. |
| Q39040207 | Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. |
| Q36893828 | Disappointing weight loss among shift workers after laparoscopic gastric bypass surgery |
| Q41844464 | Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). |
| Q46985776 | Discovery of a low-glycaemic index potato and relationship with starch digestion in vitro |
| Q83908989 | Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors |
| Q34558698 | Distribution of metals exposure and associations with cardiometabolic risk factors in the "Modeling the Epidemiologic Transition Study". |
| Q55104724 | Do Coffee Polyphenols Have a Preventive Action on Metabolic Syndrome Associated Endothelial Dysfunctions? An Assessment of the Current Evidence. |
| Q42258652 | Do In Seung Gi‑Tang extract suppresses adipocyte differentiation in 3T3‑L1 cells |
| Q79767305 | Do bioprosthetic aortic valves deteriorate more rapidly in patients with the metabolic syndrome? |
| Q58560984 | Do current guidelines for waist circumference apply to black Africans? Prediction of insulin resistance by waist circumference among Africans living in America |
| Q47369931 | Do obese patients after weight loss become metabolically normal? |
| Q34326094 | Do peer relations in adolescence influence health in adulthood? Peer problems in the school setting and the metabolic syndrome in middle-age |
| Q51276188 | Docosapentaenoic acid and docosahexaenoic acid are positively associated with insulin sensitivity in rats fed high-fat and high-fructose diets. |
| Q92025250 | Does Protein Intake Affect Metabolic Risk Factors among Older Adults in Korea? |
| Q92781170 | Does chronic hyperglycaemia increase the risk of kidney stone disease? results from a systematic review and meta-analysis |
| Q37362752 | Does lowering cholesterol have an impact on the progression of aortic stenosis? |
| Q37910060 | Does sustained weight loss reverse the metabolic syndrome? |
| Q35994352 | Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats |
| Q37012904 | Doxazosin in metabolically complicated hypertension. |
| Q34268963 | Drug therapy of hypercholesterolaemia in children and adolescents |
| Q36438737 | Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy |
| Q36753691 | Drug-induced endocrine and metabolic disorders |
| Q47237393 | Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model |
| Q36003068 | Dynamic body weight and body composition changes in response to subordination stress |
| Q38231269 | Dynamic interplay between metabolic syndrome and immunity. |
| Q55443586 | Dyslipidaemia was correlated to the posterior circulation infarction in non-diabetic populations. |
| Q42406168 | EPA prevents fat mass expansion and metabolic disturbances in mice fed with a Western diet. |
| Q58756411 | ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes |
| Q33679305 | Early Life Origins of Metabolic Syndrome: The Role of Environmental Toxicants |
| Q51434807 | Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome. |
| Q46493654 | Early development of the metabolic syndrome after chemotherapy for testicular cancer. |
| Q99623638 | Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects |
| Q36806561 | Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice |
| Q90172613 | Echocardiography Evaluation of Left Ventricular Diastolic Function in Elderly Women with Metabolic Syndrome |
| Q34219418 | Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the "adipose tissue expandability" hypothesis |
| Q34273663 | Effect of BMI on cardiovascular and metabolic syndrome risk factors in an Appalachian pediatric population |
| Q50046838 | Effect of Caloric Restriction on Metabolic Dysfunction of Young Rapacz Familial Hypercholesterolemic Swine (Sus scrofa). |
| Q35158545 | Effect of Lactobacillus plantarum Strain K21 on High-Fat Diet-Fed Obese Mice |
| Q36993410 | Effect of Maternal Age at Childbirth on Obesity in Postmenopausal Women: A Nationwide Population-Based Study in Korea |
| Q90521288 | Effect of Systemic Subnormal Deuterium Level on Metabolic Syndrome Related and other Blood Parameters in Humans: A Preliminary Study |
| Q47920529 | Effect of Tamsulosin in Lower Urinary Tract Symptom Patients With Metabolic Syndrome |
| Q46366564 | Effect of a High-Protein Diet versus Standard-Protein Diet on Weight Loss and Biomarkers of Metabolic Syndrome: A Randomized Clinical Trial |
| Q36227633 | Effect of a physical activity intervention on the metabolic syndrome in Pakistani immigrant men: a randomized controlled trial |
| Q79449752 | Effect of anthocyanin-rich extract from black rice (Oryza sativa L. indica) on hyperlipidemia and insulin resistance in fructose-fed rats |
| Q28069972 | Effect of cardiac rehabilitation on metabolic syndrome and its components: A systematic review and meta-analysis |
| Q33857214 | Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action |
| Q43765116 | Effect of dietary fat modification on subcutaneous white adipose tissue insulin sensitivity in patients with metabolic syndrome |
| Q35753767 | Effect of dietary supplementation of Bacillus subtilis B10 on biochemical and molecular parameters in the serum and liver of high-fat diet-induced obese mice |
| Q35105171 | Effect of different exercise intensities on the pancreas of animals with metabolic syndrome |
| Q37620777 | Effect of exercise intervention on changes in free Fatty Acid levels and metabolic risk factors in stroke patients |
| Q36682071 | Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes |
| Q30472847 | Effect of lifestyle intervention plus rosiglitazone or placebo therapy on left ventricular mass assessed with cardiovascular magnetic resonance in the metabolic syndrome |
| Q39871774 | Effect of long-term whole body vibration training on visceral adipose tissue: a preliminary report. |
| Q40124148 | Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients |
| Q36113307 | Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men. |
| Q41815504 | Effect of patient-optimized doses of tamsulosin on erectile function in men with erectile dysfunction and lower urinary tract symptoms |
| Q42832603 | Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats |
| Q35911869 | Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects. |
| Q46583303 | Effect of the metabolic syndrome on male reproductive function: a case-controlled pilot study |
| Q83239718 | Effect of the protein:carbohydrate ratio in hypoenergetic diets on metabolic syndrome risk factors in exercising overweight and obese women |
| Q37081323 | Effects of 12 weeks of combined exercise training on visfatin and metabolic syndrome factors in obese middle-aged women |
| Q38616803 | Effects of ABCA1 R219K Polymorphism and Serum Lipid Profiles on Mild Cognitive Impairment in Type 2 Diabetes Mellitus |
| Q46295791 | Effects of Antidiabetic Drugs on Gut Microbiota Composition |
| Q48235698 | Effects of Curcumin on Serum Vitamin E Concentrations in Individuals with Metabolic Syndrome |
| Q37728550 | Effects of Different Exercise Modes on the Urinary Metabolic Fingerprint of Men with and without Metabolic Syndrome. |
| Q42685826 | Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats |
| Q33808498 | Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study |
| Q35654112 | Effects of Obesity and Metabolic Syndrome on Steroidogenesis and Folliculogenesis in the Female Ossabaw Mini-Pig |
| Q46652917 | Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials |
| Q92592260 | Effects of Selenium Supplementation on Cardiometabolic Risk Factors, Inflammatory, and Antioxidant Markers: A Systematic Review and Meta-analysis Protocol |
| Q57266934 | Effects of a Single and Short-Term Ingestion of Diacylglycerol on Fat Oxidation in Rats |
| Q37542068 | Effects of a lifestyle modification programme to reduce the number of risk factors for metabolic syndrome: a randomised controlled trial |
| Q36134981 | Effects of a physical activity program on markers of endothelial dysfunction, oxidative stress, and metabolic status in adolescents with metabolic syndrome |
| Q51385895 | Effects of a therapeutic lifestyle modification program on inflammatory chemokines and insulin resistance in subjects with metabolic syndrome. |
| Q42494445 | Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients |
| Q37083013 | Effects of alternate fasting or very low calorie diet and low calorie diet on metabolic syndrome in severely obese patients |
| Q46452387 | Effects of an intervention in eating habits and physical activity in Japanese-Brazilian women with a high prevalence of metabolic syndrome in Bauru, São Paulo State, Brazil. |
| Q44481818 | Effects of angiotensin II receptor blockers on insulin resistance |
| Q51321591 | Effects of black tea on body composition and metabolic outcomes related to cardiovascular disease risk: a randomized controlled trial. |
| Q37452687 | Effects of caloric restriction on cardiovascular aging in non-human primates and humans |
| Q42763240 | Effects of canola and high-oleic-acid canola oils on abdominal fat mass in individuals with central obesity. |
| Q36311039 | Effects of combined exercise training on body composition and metabolic syndrome factors. |
| Q36171156 | Effects of diet and development on the Drosophila lipidome |
| Q43177123 | Effects of dietary fat modification on skeletal muscle fatty acid handling in the metabolic syndrome. |
| Q36835871 | Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study |
| Q36944124 | Effects of eprosartan on serum metabolic parameters in patients with essential hypertension |
| Q46659452 | Effects of heat-inactivated Lactobacillus gasseri TMC0356 on metabolic characteristics and immunity of rats with the metabolic syndrome |
| Q84479915 | Effects of low-fat dairy consumption on markers of low-grade systemic inflammation and endothelial function in overweight and obese subjects: an intervention study |
| Q43235044 | Effects of magnesium on postprandial serum lipid responses in healthy human subjects. |
| Q42963291 | Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome |
| Q46289521 | Effects of microencapsulated Lactobacillus plantarum LIP-1 on the gut microbiota of hyperlipidaemic rats |
| Q51468305 | Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. |
| Q51294392 | Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome. |
| Q89566802 | Effects of pharmacopuncture with wild ginseng complex in 2 elderly patients with obesity: Case report |
| Q79986554 | Effects of post-absorptive and postprandial exercise on glucoregulation in metabolic syndrome |
| Q51477953 | Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. |
| Q50603440 | Effects of short- and long-term Mediterranean-based dietary treatment on plasma LC-QTOF/MS metabolic profiling of subjects with metabolic syndrome features: The Metabolic Syndrome Reduction in Navarra (RESMENA) randomized controlled trial. |
| Q35222441 | Effects on metabolic health after a 1-year-lifestyle intervention in overweight and obese children: a randomized controlled trial |
| Q38075153 | Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs. |
| Q60209721 | Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study |
| Q46651019 | Efficacy of Ace Inhibition with Zofenopril, Lisinopril, or Ramipril in Postacute Myocardial Infarction Patients With or Without Metabolic Syndrome: A Pooled Individual Data Analysis of Four Randomized, Double-Blind, Controlled, Prospective Studies |
| Q91785438 | Efficacy of Ginger (Zingiber officinale) in Ameliorating Streptozotocin-Induced Diabetic Liver Injury in Rats: Histological and Biochemical Studies |
| Q64070561 | Eight-week of low-intensive lifestyle modification does improve insulin resistance in adults with metabolic syndrome |
| Q36916772 | Elderly women with metabolic syndrome present higher cardiovascular risk and lower relative muscle strength. |
| Q34114452 | Electroacupuncture decreases the leukocyte infiltration to white adipose tissue and attenuates inflammatory response in high fat diet-induced obesity rats. |
| Q38462847 | Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes |
| Q49180208 | Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome. |
| Q35063759 | Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studies |
| Q37738417 | Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity |
| Q35744930 | Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study |
| Q34482016 | Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance |
| Q36705709 | Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women |
| Q34347884 | Emerging gliptins for type 2 diabetes |
| Q48479771 | Employing in vitro analysis to test the potency of methylglyoxal in inducing the formation of amyloid-like aggregates of caprine brain cystatin. |
| Q36891589 | Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. |
| Q37724743 | Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats |
| Q36986975 | Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial |
| Q47362824 | Epicardial adipose tissue and metabolic syndrome in hypertensive patients with normal body weight and waist circumference. |
| Q40513444 | Epicardial adipose tissue and signs of metabolic syndrome in children. |
| Q36795877 | Epicardial fat: properties, function and relationship to obesity |
| Q51938302 | Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes. |
| Q36982752 | Epidemiology and genetics of calcific aortic valve disease |
| Q24629433 | Epidemiology of gallbladder disease: cholelithiasis and cancer |
| Q34475017 | Epidemiology of general obesity, abdominal obesity and related risk factors in urban adults from 33 communities of Northeast China: the CHPSNE study |
| Q90524253 | Erythrocyte PUFAs, circulating acylcarnitines, and metabolic syndrome risk: a prospective study in Chinese |
| Q46087577 | Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance |
| Q37058767 | Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation |
| Q34481216 | Estrogen signaling in metabolic inflammation |
| Q34603569 | Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action |
| Q46278993 | Ethnic differences in body composition and other markers of cardiovascular disease risk: study in matched Haitian and White subjects from Quebec |
| Q51473862 | Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. |
| Q35746178 | Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults |
| Q58617678 | Evaluation of Agraz Consumption on Adipocytokines, Inflammation, and Oxidative Stress Markers in Women with Metabolic Syndrome |
| Q64902738 | Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia |
| Q38944607 | Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine. |
| Q36826803 | Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus |
| Q34159256 | Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome. |
| Q43300831 | Evaluation of the quality of medical care in primary care patients with metabolic syndrome |
| Q55283962 | Evidence Based Laboratory Medicine in the Diagnosis of Metabolic Syndrome. |
| Q48275077 | Evidence of alterations in the expression of orphan receptors GPR26 and GPR39 due to the etiology of the metabolic syndrome |
| Q42049436 | Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin |
| Q34131274 | Excess weight and the risk of incident coronary heart disease among men and women |
| Q37083011 | Excessive body iron stores are not associated with risk of coronary heart disease in women |
| Q36102382 | Exercise in the metabolic syndrome |
| Q26822992 | Exercise induced adipokine changes and the metabolic syndrome |
| Q90472655 | Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis |
| Q35985220 | Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases |
| Q38383259 | Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. |
| Q36239426 | Exploring the origins of asthma: Lessons from twin studies |
| Q46030893 | Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. |
| Q42033362 | Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice. |
| Q36296929 | Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis |
| Q49359562 | FGF21-induced by carbon monoxide mediates metabolic homeostasis via the PERK/ATF4 pathway. |
| Q35857264 | Factors Affecting Gender Differences in the Association between Health-Related Quality of Life and Metabolic Syndrome Components: Tehran Lipid and Glucose Study |
| Q58775912 | Factors Associated with Atraumatic Posterosuperior Rotator Cuff Tears |
| Q33819636 | Factors associated with metabolic syndrome in a mediterranean population: role of caffeinated beverages |
| Q38077655 | Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin? |
| Q92425544 | Familial Resemblance in Body Shape and Composition, Metabolic Syndrome, Physical Activity and Physical Fitness: A Summary of Research in Portuguese Families and Siblings |
| Q28581627 | Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation |
| Q36519849 | Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults |
| Q53365082 | Fat and carbohydrate content in the diet induces drastic changes in gene expression in young Göttingen minipigs. |
| Q55054161 | Fat redistribution following suction lipectomy: defense of body fat and patterns of restoration. |
| Q26859157 | Fatty acids, obesity, and insulin resistance: time for a reevaluation |
| Q84078755 | Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome |
| Q79547896 | Favorable effects of non-instrumental resistance training on fat distribution and metabolic profiles in healthy elderly people |
| Q43096513 | Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study |
| Q89899821 | Fecal Viral Community Responses to High-Fat Diet in Mice |
| Q92871593 | Feedback on Physical Activity Through a Wearable Device Connected to a Mobile Phone App in Patients With Metabolic Syndrome: Pilot Study |
| Q91606940 | Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly |
| Q36753736 | Fiber-free white flour with fructose offers a better model of metabolic syndrome. |
| Q35931224 | Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? |
| Q43034053 | Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis |
| Q37355770 | Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial |
| Q39126975 | First report on path analysis for cardiometabolic components in a nationally representative sample of pediatric population in the Middle East and North Africa (MENA): the CASPIAN-III Study |
| Q33750232 | First-borns carry a higher metabolic risk in early adulthood: evidence from a prospective cohort study |
| Q34410218 | Fish consumption and its possible preventive role on the development and prevalence of metabolic syndrome - a systematic review |
| Q41679810 | Fish oil prevents excessive accumulation of subcutaneous fat caused by an adverse effect of pioglitazone treatment and positively changes adipocytes in KK mice |
| Q37389128 | Fish oil supplementation ameliorates fructose-induced hypertriglyceridemia and insulin resistance in adult male rhesus macaques |
| Q36572717 | Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies. |
| Q33705889 | Five common haplotype-tagging variants of adiponectin (ADIPOQ) and cancer susceptibility: a meta-analysis |
| Q36720582 | Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome |
| Q51863213 | Food group intake and central obesity among children and adolescents in the Third National Health and Nutrition Examination Survey (NHANES III). |
| Q26765503 | Fortifying the Treatment of Prostate Cancer with Physical Activity |
| Q36300077 | FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases |
| Q37705903 | Framingham cardiovascular risk in patients with obesity and periodontitis. |
| Q27001123 | Free Fatty acids and their metabolism affect function and survival of podocytes |
| Q34591439 | Free triiodothyronine concentrations are inversely associated with microalbuminuria. |
| Q41633723 | Frequency of metabolic syndrome in patients with knuckle pads. |
| Q36640868 | Freshwater Clam Extract Ameliorates Triglyceride and Cholesterol Metabolism through the Expression of Genes Involved in Hepatic Lipogenesis and Cholesterol Degradation in Rats |
| Q38011507 | From excess adiposity to insulin resistance: the role of free fatty acids |
| Q40806527 | Fructose induces prothrombotic phenotype in human endothelial cells : A new role for "added sugar" in cardio-metabolic risk |
| Q35205907 | Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes |
| Q45955316 | Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. |
| Q49903270 | Fruit and vegetable consumption and risk of the metabolic syndrome: a meta-analysis. |
| Q46568945 | Functional relationships between serum total cholesterol levels, executive control, and sustained attention |
| Q84041000 | G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome |
| Q41068208 | Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial. |
| Q34634193 | Gallstone disease |
| Q51487572 | Gastric electrical activity and cardiovascular risk factors in relation to autonomic nervous function, hormonal responses, and health-related lifestyles in young men. |
| Q51285414 | Gemigliptin ameliorates Western-diet-induced metabolic syndrome in mice. |
| Q39951037 | Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population |
| Q51765294 | Gender and genetic differences in bladder smooth muscle PPAR mRNA in a porcine model of the metabolic syndrome. |
| Q37044313 | Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease |
| Q40159032 | Gender differences in severity of sickle cell diseases in non-smokers. |
| Q37253336 | Gender differences in the association between metabolic syndrome and periodontal disease: the Hisayama Study |
| Q36441958 | Gender differences in the metabolic syndrome and their role for cardiovascular disease. |
| Q58130830 | Gender differences in the relationship between serum zinc concentration and metabolic syndrome |
| Q37314634 | Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure |
| Q57198024 | Gender-specific associations between perceived and objective neighbourhood crime and metabolic syndrome |
| Q43267036 | Gender-specific care of diabetes |
| Q37169720 | Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women |
| Q80983697 | Generalised and abdominal obesity and risk of diabetes, hypertension and hypertension-diabetes co-morbidity in England |
| Q36190263 | Generation and esterification of electrophilic fatty acid nitroalkenes in triacylglycerides |
| Q55423014 | Genetic Succeptibility to Metabolic Syndrome. |
| Q36367726 | Genetic Variants in Six-Transmembrane Epithelial Antigen of Prostate 4 Increase Risk of Developing Metabolic Syndrome in a Han Chinese Population |
| Q37154939 | Genetic and environmental contributions to phenotypic components of metabolic syndrome: a population-based twin study |
| Q63432883 | Genetic control of plasma lipid levels in a cross derived from normoglycaemic Brown Norway and spontaneously diabetic Goto–Kakizaki rats |
| Q34560555 | Genetic determinants of the metabolic syndrome |
| Q37900363 | Genetic variants and the metabolic syndrome: a systematic review |
| Q37599633 | Genetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal |
| Q24294598 | Genetic variation in SCN10A influences cardiac conduction |
| Q81478270 | Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives |
| Q35944277 | Genetic view on the phenomenon of combined diseases in man. |
| Q37625006 | Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome |
| Q37733662 | Genome-wide hepatic DNA methylation changes in high-fat diet-induced obese mice. |
| Q28943337 | Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits |
| Q90726978 | Geospatial patterns of access to self-care resources for obesity among endometrial cancer survivors in a high poverty urban community |
| Q38112797 | Germinated grains: a superior whole grain functional food? |
| Q38646168 | Gestational weight gain in obese pregnancy: impact on maternal and foetal metabolic parameters and birthweight |
| Q37544169 | Global Metabolic Profiling of Plasma Shows that Three-Year Mild-Caloric Restriction Lessens an Age-Related Increase in Sphingomyelin and Reduces L-leucine and L-phenylalanine in Overweight and Obese Subjects |
| Q34635085 | Global left ventricular performance in non-diabetic non-hypertensive metabolic syndrome adults |
| Q92604913 | Global prevalence of cardiometabolic risk factors in the military population: a systematic review and meta-analysis |
| Q83534471 | Glucose intolerance in renal transplant recipients is associated with increased urinary albumin excretion |
| Q82852541 | Glucose metabolism and body composition in young adults treated with TBI during childhood |
| Q37249085 | Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice |
| Q36757006 | Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study. |
| Q37939978 | Glycemic impact and health: new horizons in white bread formulations. |
| Q38669170 | Glycogen phosphorylase inhibitors: a patent review (2013 - 2015). |
| Q34578006 | Glycyrrhizic acid can attenuate metabolic deviations caused by a high-sucrose diet without causing water retention in male Sprague-Dawley rats |
| Q46665032 | Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model |
| Q53295726 | Grape seed proanthocyanidin extract ameliorates inflammation and adiposity by modulating gut microbiota in high-fat diet mice. |
| Q35107872 | Greater healthful food variety as measured by the US Healthy Food Diversity index is associated with lower odds of metabolic syndrome and its components in US adults |
| Q22306331 | Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association |
| Q37141253 | Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q84595609 | Guiding clinical decisions on abdominal obesity and cardiometabolic risk |
| Q34866320 | Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. |
| Q34669782 | Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation |
| Q57289950 | Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration |
| Q39174701 | HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis. |
| Q38242739 | HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis |
| Q36742564 | Health risks associated with overweight and obesity |
| Q90746506 | Health-Related Quality of Life in Tehran Lipid and Glucose Study |
| Q64881397 | Health-related behavior of the people who neglect the specific health guidance for metabolic syndrome control. |
| Q35960796 | Heart disease is common in humans and chimpanzees, but is caused by different pathological processes |
| Q34063737 | Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas |
| Q33718251 | Helicobacter pylori infection: new pathogenetic and clinical aspects |
| Q51490311 | Hemostasis and glycemic control in the cardiac surgical patient. |
| Q82816416 | Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding |
| Q28389287 | Hepatic oxidative stress, genotoxicity and vascular dysfunction in lean or obese Zucker rats |
| Q28595534 | Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects |
| Q42330055 | Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade |
| Q51665999 | Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. |
| Q37157342 | Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. |
| Q92631642 | Herba Houttuyniae Extract Benefits Hyperlipidemic Mice via Activation of the AMPK/PGC-1α/Nrf2 Cascade |
| Q26740415 | Herbal Medicines for Treating Metabolic Syndrome: A Systematic Review of Randomized Controlled Trials |
| Q30410470 | Heritability of metabolic syndrome traits in a large population-based sample |
| Q37089762 | Hexarelin Signaling to PPARgamma in Metabolic Diseases |
| Q38937412 | High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex |
| Q64248770 | High Carbohydrate High Fat Diet Induced Hepatic Steatosis and Dyslipidemia Were Ameliorated by Psidium guajava Leaf Powder Supplementation in Rats |
| Q64281561 | High Density Lipoprotein from Egg Yolk (EYHDL) Improves Dyslipidemia by Mediating Fatty Acids Metabolism in High Fat Diet-induced Obese Mice |
| Q33616618 | High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions |
| Q58420538 | High Prevalence of the Metabolic Syndrome in Iranian Adolescents* |
| Q34330096 | High fat diet induces adhesion of platelets to endothelium in two models of dyslipidemia |
| Q34432886 | High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease. |
| Q35155152 | High prevalence of low HDL-c in the Philippines compared to the US: population differences in associations with diet and BMI. |
| Q39077887 | High prevalence of metabolic syndrome in a middle-aged and elderly population with prehypertension in Tianjin |
| Q39961902 | High prevalence of metabolic syndrome in an elderly Croatian population - a multicentre study |
| Q92579578 | High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes |
| Q34437265 | High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome |
| Q36812421 | High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague-Dawley Rat |
| Q36081837 | High-normal Glucose Levels in Non-diabetic and Pre-diabetic Men Are Associated with Decreased Testosterone Levels. |
| Q35059230 | High-resolution time-of-flight mass spectrometry fingerprinting of metabolites from cecum and distal colon contents of rats fed resistant starch |
| Q37672346 | Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis |
| Q43274967 | Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome |
| Q36634377 | Histological assessment of non-alcoholic fatty liver disease |
| Q88346940 | Homeostatic Model Assessment-Insulin Resistance (HOMA-IR 2) in Mild Subclinical Hypothyroid Subjects |
| Q43809679 | Host-Microbiota Mutualism in Metabolic Diseases |
| Q39356625 | How coffee affects metabolic syndrome and its components |
| Q35177141 | How do high glycemic load diets influence coronary heart disease? |
| Q36383027 | How to best define the metabolic syndrome |
| Q34066540 | Human C-reactive protein and the metabolic syndrome |
| Q36359102 | Human genetics of adiponectin in the metabolic syndrome |
| Q33589138 | Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress |
| Q80243420 | Human visceral adipose tissue and the plasminogen activator inhibitor type 1 |
| Q99567276 | Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats |
| Q37362687 | Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world |
| Q36839928 | Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update |
| Q47547144 | Hypertension, diabetes and obesity are associated with lower cognitive performance in community-dwelling elderly: Data from the FIBRA study. |
| Q37826799 | Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers |
| Q36369676 | Hypertension--a treatable component of the cardiometabolic syndrome: challenges for the primary care physician |
| Q37364955 | Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes |
| Q36969065 | Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? |
| Q35332690 | Hyperuricemia as a Potential Determinant of Metabolic Syndrome. |
| Q95839803 | Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu |
| Q50929940 | Hypolipidemic effect of Youcha in hyperlipidemia rats induced by high-fat diet. |
| Q36408527 | Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning |
| Q58093829 | Hypothalamic Inflammation at a Crossroad of Somatic Diseases |
| Q35318592 | Hypothalamic inflammation: a double-edged sword to nutritional diseases |
| Q35735140 | I've Got You Under My Skin: Marital Biography and Biological Risk |
| Q37305013 | IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies |
| Q41851616 | IRS1, TCF7L2, ADRB1, PPARG, and HHEX polymorphisms associated with atherogenic risk in Mexican population. |
| Q24650184 | Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism |
| Q38640616 | Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects. |
| Q58798940 | Identification of an obesity index for predicting metabolic syndrome by gender: the rural Chinese cohort study |
| Q33765653 | Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity |
| Q35934104 | Identification of important chemical features of 11β-hydroxysteroid dehydrogenase type1 inhibitors: application of ligand based virtual screening and density functional theory |
| Q89905931 | Identification of metabolic syndrome using phenotypes consisting of triglyceride levels with anthropometric indices in Korean adults |
| Q53199534 | Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload. |
| Q36120514 | Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population |
| Q34498817 | Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors |
| Q37700032 | Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes |
| Q44003405 | Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study |
| Q45216579 | Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study |
| Q34620510 | Imaging body composition in obesity and weight loss: challenges and opportunities. |
| Q34436072 | Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease |
| Q47743748 | Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients |
| Q50068164 | Impact of Adrenal Steroids on Regulation of Adipose Tissue. |
| Q27318055 | Impact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS) |
| Q36194202 | Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome |
| Q36329909 | Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome |
| Q37622148 | Impact of Serum Leptin to Adiponectin Ratio on Regression of Metabolic Syndrome in High-Risk Individuals: The ARIRANG Study |
| Q35810003 | Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis |
| Q33853862 | Impact of dietary polyphenols on carbohydrate metabolism |
| Q36501334 | Impact of diets and nutrients/drugs on early epigenetic programming |
| Q87107942 | Impact of metabolic syndrome components on incident stroke subtypes: a Chinese cohort study |
| Q86976878 | Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients |
| Q37129540 | Impact of metabolic syndrome on lipid target achievements in the Arabian Gulf: findings from the CEPHEUS study. |
| Q39631387 | Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study |
| Q34979675 | Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model |
| Q33585816 | Impact of obesity with impaired glucose tolerance on retinal degeneration in a rat model of metabolic syndrome |
| Q35031383 | Impact of probiotics on risk factors for cardiovascular diseases. A review |
| Q40133099 | Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. |
| Q36944112 | Impact of the L-arginine-Nitric Oxide Pathway and Oxidative Stress on the Pathogenesis of the Metabolic Syndrome |
| Q47147666 | Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease |
| Q42403509 | Impaired glucose tolerance in acute pancreatitis |
| Q79216206 | Impaired lung function is associated with obesity and metabolic syndrome in adults |
| Q38903173 | Implication of corticotropic hormone axis in eating behaviour pattern in obese and type 2 diabetic participants. |
| Q43511282 | Implication of genetic variants near TMEM18, BCDIN3D/FAIM2, and MC4R with coronary artery disease and obesity in Chinese: a angiography-based study |
| Q57718011 | Implications for kidney disease in obese children and adolescents |
| Q100737199 | Implications of metabolism-driven myeloid dysfunctions in cancer therapy |
| Q47097279 | Importance of Different Grades of Abdominal Obesity on Testosterone Level, Erectile Dysfunction, and Clinical Coincidence |
| Q35628633 | Importance of both fatness and aerobic fitness on metabolic syndrome risk in Japanese children |
| Q48424702 | Improvement of cardiovascular risk profile in an elderly population of low social level: the ICON (Improving Cardiovascular risk profile in Older Neapolitans) study. |
| Q36676781 | Improvement of liquid fructose-induced adipose tissue insulin resistance by ginger treatment in rats is associated with suppression of adipose macrophage-related proinflammatory cytokines |
| Q37105779 | Improvements in the metabolic syndrome and stages of change for lifestyle behaviors in korean older adults |
| Q52567148 | In Vitro and in Vivo Inhibition of Intestinal Glucose Transport by Guava (Psidium Guajava) Extracts. |
| Q35925936 | In adenosine A2B knockouts acute treatment with inorganic nitrate improves glucose disposal, oxidative stress, and AMPK signaling in the liver |
| Q80387764 | In vivo assessment of cardiac insulin resistance by nuclear probes using an iodinated tracer of glucose transport |
| Q33813278 | Inactivation of the Rcan2 gene in mice ameliorates the age- and diet-induced obesity by causing a reduction in food intake |
| Q39911700 | Incidence and risk factors for the metabolic syndrome in an urban South European population |
| Q35855960 | Incidence of Metabolic Syndrome and Its Risk Factors among Type 2 Diabetes Clinic Attenders in Isfahan, Iran |
| Q89748084 | Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study |
| Q37378763 | Incidence of metabolic syndrome and relative importance of five components as a predictor of metabolic syndrome: 5-year follow-up study in Korea |
| Q36148595 | Inclusion of biomarkers for detecting perturbations in the heart and lung and lipid/carbohydrate metabolism in National Toxicology Program studies |
| Q36271979 | Increased Epicardial Adipose Tissue Thickness in Type 2 Diabetes Mellitus and Obesity |
| Q35806849 | Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients |
| Q34082813 | Increased brain fatty acid uptake in metabolic syndrome |
| Q42396896 | Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages |
| Q33566553 | Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome |
| Q40041917 | Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes |
| Q35086458 | Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis |
| Q35841261 | Increased toll-like receptor activity in patients with metabolic syndrome |
| Q37060889 | Increased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetes |
| Q51369415 | Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. |
| Q39098422 | Increasing parental age at childbirth is associated with greater insulin sensitivity and more favorable metabolic profile in overweight adult male offspring |
| Q34357035 | Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q37577140 | Individualization of antihypertensive drug treatment |
| Q92783034 | Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation |
| Q39396943 | Induction of Type 2 Diabetes Mellitus with Antihypertensive Therapy: Is There Any Role of Alpha Adducin, ACE, and IRS-1 Gene? |
| Q34599296 | Inference of cross-level interaction between genes and contextual factors in a matched case-control metabolic syndrome study: a Bayesian approach |
| Q40899161 | Inflamed fat: what starts the fire? |
| Q58594757 | Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population |
| Q35533932 | Inflammation and the metabolic syndrome |
| Q36674320 | Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress |
| Q35864675 | Inflammation as a Link between Obesity and Metabolic Syndrome |
| Q36643542 | Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. |
| Q35857192 | Inflammatory cause of metabolic syndrome via brain stress and NF-κB. |
| Q37680661 | Inflammatory lipid mediators in adipocyte function and obesity. |
| Q51878622 | Inflammatory markers in relation to insulin resistance and the metabolic syndrome. |
| Q36738578 | Inflammatory status in older women with and without metabolic syndrome: is there a correlation with risk factors? |
| Q51753169 | Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis. |
| Q92812693 | Influence of Cardiometabolic Risk Factors on Platelet Function |
| Q59866796 | Influence of Diet and Gender on Plasma DPP4 Activity and GLP-1 in Patients with Metabolic Syndrome: An Experimental Pilot Study |
| Q36012419 | Influence of change in aerobic fitness and weight on prevalence of metabolic syndrome |
| Q43554757 | Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study |
| Q37117800 | Influence of early-life nutrition on mortality and reproductive success during a subsequent famine in a preindustrial population. |
| Q45365434 | Influence of exercise on NA- and Hsp72-induced release of IFNγ by the peritoneal suspension of macrophages and lymphocytes from genetically obese Zucker rats. |
| Q84422270 | Influence of exercise on the circulating levels and macrophage production of IL-1beta and IFNgamma affected by metabolic syndrome: an obese Zucker rat experimental animal model |
| Q35927767 | Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome |
| Q42803875 | Influence of resveratrol on endoplasmic reticulum stress and expression of adipokines in adipose tissues/adipocytes induced by high-calorie diet or palmitic acid |
| Q48127639 | Influencing factors in quantitative measurement using activated platelet levels and platelet-activating capacity for the assessment of thrombosis in pre-metabolic syndrome and type 2 diabetes mellitus. |
| Q35718324 | Inhalation of carbon monoxide is ineffective as a long-term therapy to reduce obesity in mice fed a high fat diet |
| Q92081629 | Inhibition of endoplasmic reticulum stress ameliorates cardiovascular injury in a rat model of metabolic syndrome |
| Q47415402 | Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome. |
| Q84468333 | Insight on pathogenesis of lifelong premature ejaculation: inverse relationship between lifelong premature ejaculation and obesity |
| Q33671928 | Insights from engraftable immunodeficient mouse models of hyperinsulinaemia. |
| Q37061741 | Instability in the diagnosis of metabolic syndrome in adolescents |
| Q58197697 | Insulin Primes Human Neutrophils for CCL3-Induced Migration: Crucial Role for JNK 1/2 |
| Q39904305 | Insulin Resistance as a Novel Risk Factor for Post-ERCP Pancreatitis: A Pilot Study. |
| Q46233604 | Insulin and cholesterol gallstones: new insights for a complex pathogenic relationship |
| Q37239619 | Insulin and the lung: connecting asthma and metabolic syndrome |
| Q33592719 | Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. |
| Q42726120 | Insulin resistance and hepatitis C. |
| Q37228658 | Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. |
| Q46798133 | Insulin resistance and secretion assessment across a range of glucose tolerance from normal individuals through diabetes |
| Q37000702 | Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis |
| Q37448971 | Insulin resistance in pulmonary arterial hypertension |
| Q35712246 | Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study |
| Q85290845 | Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer |
| Q35871387 | Insulin resistance, metabolic stress, and atherosclerosis |
| Q35683999 | Insulin resistance: Is it time for primary prevention? |
| Q36741853 | Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability |
| Q33728538 | Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach |
| Q44739166 | Insulin sensitivity modifies the relationship between thyroid function and lipid profile in euthyroid type 1 diabetic patients |
| Q33865096 | Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms |
| Q50924107 | Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort. |
| Q24246323 | Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome |
| Q48216518 | Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction |
| Q34976178 | Integrated Solution for Physical Activity Monitoring Based on Mobile Phone and PC |
| Q37734929 | Integrated Yoga and Naturopathy module in management of Metabolic Syndrome: A case report |
| Q41885229 | Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators. |
| Q35635352 | Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis |
| Q43253088 | Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice |
| Q47285927 | Interleukin-18: Biological properties and role in disease pathogenesis |
| Q59800584 | Interplay of atherogenic factors, protein intake and betatrophin levels in obese–metabolic syndrome patients treated with hypocaloric diets |
| Q90217787 | Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr-/- mice |
| Q35775685 | Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice |
| Q99411663 | Intra-abdominal fat accumulation is an important predictor of metabolic syndrome in young adults |
| Q36527946 | Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation |
| Q43272788 | Intrauterine growth restriction: no unifying risk factor for the metabolic syndrome in young adults |
| Q55177462 | Intrauterine hyperglycemia exposure results in intergenerational inheritance via DNA methylation reprogramming on F1 PGCs. |
| Q37607617 | Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans |
| Q59329358 | Inverse Relationship between Metabolic Syndrome and 25-Hydroxyvitamin D Concentration in Elderly People without Vitamin D deficiency |
| Q28535034 | Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure |
| Q28069653 | Investigating the Metabolic Syndrome: Contributions of Swine Models |
| Q38348993 | Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice. |
| Q26828547 | Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity |
| Q33819735 | Involvement of oxidative stress in atherosclerosis development in subjects with sarcopenic obesity |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q39011514 | Irregular eating of meals in adolescence and the metabolic syndrome in adulthood: results from a 27-year prospective cohort |
| Q46131065 | Is dental caries experience associated with adiposity status in preschool children? |
| Q85921628 | Is it "science"… or is it "turf" guarding? |
| Q51373445 | Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? |
| Q51736579 | Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? |
| Q37680578 | Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? |
| Q35510256 | Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. |
| Q33724123 | Is there a paradox in obesity? |
| Q34348797 | JNK regulation of hepatic manifestations of the metabolic syndrome |
| Q39936507 | JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats |
| Q35876408 | K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome |
| Q37344018 | Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis |
| Q26749229 | Knowledge of healthy lifestyle in Iran: a systematic review |
| Q36396625 | Knowledge, perceptions, and attitudes of dental students towards obesity |
| Q37457235 | LXRα fuels fatty acid-stimulated oxygen consumption in white adipocytes |
| Q42873632 | Large-scale population analysis reveals an extremely low threshold for "non-healthy" alanine aminotransferase that predicts diabetes mellitus |
| Q39176676 | Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study |
| Q33945716 | Latent class analysis of the metabolic syndrome |
| Q37729747 | Lean Fish Consumption Is Associated with Beneficial Changes in the Metabolic Syndrome Components: A 13-Year Follow-Up Study from the Norwegian Tromsø Study |
| Q46973489 | Learning from tesaglitazar |
| Q55433983 | Leea macrophylla Roxb. leaf extract potentially helps normalize islet of β‐cells damaged in STZ‐induced albino rats. |
| Q33911147 | Left renal atrophy |
| Q36694061 | Leisure-time physical activity and its association with metabolic risk factors in Iranian adults: Tehran Lipid and Glucose Study, 2005-2008 |
| Q33932824 | Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study |
| Q61815218 | Leptin gene G2548A polymorphism among Mongolians with metabolic syndrome |
| Q34406436 | Leptin in hepatocellular carcinoma |
| Q54325643 | Leucaena leucocephala fruit aqueous extract stimulates adipogenesis, lipolysis, and glucose uptake in primary rat adipocytes. |
| Q48465860 | Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study. |
| Q57297429 | Life Course Effects of Socioeconomic and Lifestyle Factors on Metabolic Syndrome and 10-Year Risk of Cardiovascular Disease: A Longitudinal Study in Taiwan Adults |
| Q37304363 | Lifestyle approach for type 2 diabetes and metabolic syndrome. |
| Q51854602 | Lifestyle changes are related to reductions in depression in persons with elevated coronary risk factors. |
| Q35397554 | Lifestyle-related factors and their association with metabolic syndrome in Korean adults: a population-based study |
| Q92861522 | Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology |
| Q53811311 | Links and risks associated with psoriasis and metabolic syndrome. |
| Q37736008 | Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism |
| Q37576121 | Lipid lowering and aortic valve disease |
| Q57559787 | Lipid, protein and carbohydrate intake in relation to body mass index: an Italian study |
| Q37900938 | Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. |
| Q38132847 | Lipoproteins and Hedgehog signalling--possible implications for the adrenal gland function |
| Q27332377 | Lipoproteins in Drosophila melanogaster--assembly, function, and influence on tissue lipid composition |
| Q42174181 | Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia. |
| Q37224466 | Liver diseases and metabolic syndrome |
| Q37682644 | Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals |
| Q39983308 | Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement. |
| Q50026039 | Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat. |
| Q87934555 | Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy |
| Q35995225 | Long-term effect of early postnatal overnutrition on insulin resistance and serum fatty acid profiles in male rats |
| Q51369544 | Long-term prognostic implications of metabolic syndrome in heart transplant recipients. |
| Q59336371 | Longitudinal association between obesity and periodontal diseases among secondary school students in Hong Kong: a prospective cohort study |
| Q33519234 | Longitudinal trends in the association of metabolic syndrome with 550 k single-nucleotide polymorphisms in the Framingham Heart Study. |
| Q36847534 | Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis |
| Q36846099 | Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice |
| Q39445955 | Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s |
| Q30497410 | Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia |
| Q48269588 | Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma. |
| Q51368398 | Low urine pH Is a predictor of chronic kidney disease. |
| Q36415848 | Low-carbohydrate or low-fat diets for the metabolic syndrome? |
| Q35722901 | Lower Circulating C1q/TNF-Related Protein-3 (CTRP3) Levels Are Associated with Obesity: A Cross-Sectional Study |
| Q47817278 | Lower HDL-cholesterol among healthy middle-aged Japanese-Brazilians in São Paulo compared to Natives and Japanese-Brazilians in Japan. |
| Q48691585 | Lower physical activity, but not excessive calorie intake, is associated with metabolic syndrome in elderly with type 2 diabetes mellitus: the Japanese Elderly Diabetes Intervention Trial. |
| Q36409135 | Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology |
| Q37537765 | Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity |
| Q92862044 | Lysosomal acid lipase deficiency - early diagnosis is the key |
| Q48086135 | METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial. |
| Q41949841 | MG53's new identity. |
| Q36902710 | Magnesium intake and the metabolic syndrome: epidemiologic evidence to date |
| Q28551574 | Magnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss Program |
| Q38631199 | Management of gallstones and its related complications |
| Q42736692 | Management of liver cirrhosis between primary care and specialists |
| Q36333931 | Management of patients with type 2 diabetes after acute coronary syndromes |
| Q46714886 | Management of the metabolic syndrome in cardiovascular disease |
| Q36561361 | Managing cardiovascular risk in menopausal women |
| Q36563115 | Managing cardiovascular risk in patients with metabolic syndrome |
| Q34030689 | Managing metabolic syndrome in women |
| Q37965730 | Mapping body fat distribution: a key step towards the identification of the vulnerable patient? |
| Q28070329 | Marine Algae as a Potential Source for Anti-Obesity Agents |
| Q39039584 | Marital quality, depressive symptoms, and the metabolic syndrome: a couples structural model |
| Q33871861 | Maternal nutrient restriction between early and midgestation and its impact upon appetite regulation after juvenile obesity |
| Q38546978 | Maternal obesity in females born small: Pregnancy complications and offspring disease risk |
| Q36668223 | Matured hop extract reduces body fat in healthy overweight humans: a randomized, double-blind, placebo-controlled parallel group study |
| Q34236425 | Measuring FMD in the brachial artery: how important is QRS gating? |
| Q34020219 | Measuring the improvement in health-related quality of life using King's health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study |
| Q39388330 | Mechanisms and Therapeutic Relevance of Neuro-immune Communication. |
| Q34532694 | Mechanisms of cerebrovascular protection: oestrogen, inflammation and mitochondria |
| Q37597592 | Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction |
| Q51476172 | Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. |
| Q34528349 | Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver |
| Q36654960 | Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy |
| Q36466438 | Mediation of cognitive function by high fat diet following stress and inflammation |
| Q44081388 | Melanocortin-4 receptor polymorphisms in Turkish pediatric obese patients |
| Q38336854 | Mercury and metabolic syndrome: a review of experimental and clinical observations. |
| Q58553707 | Meta-Analysis of Adiponectin as a Biomarker for the Detection of Metabolic Syndrome |
| Q54212460 | Meta-analysis reveals a specific association of the PNPLA3 I148M polymorphism with ALT level in adolescents. |
| Q37543331 | Metabolic Derangements in Lichen Planus - A Case Control Study |
| Q39280816 | Metabolic Flexibility in Health and Disease |
| Q40909220 | Metabolic Syndrome Prevalence and Correlates in a Worksite Wellness Program |
| Q60935440 | Metabolic Syndrome Prevalence in Students Attending West Virginia University |
| Q37636997 | Metabolic Syndrome Prevalence in an Urban African American Population |
| Q59052194 | Metabolic Syndrome according to Three Definitions in Hammam-Sousse Sahloul Heart Study: A City Based Tunisian Study |
| Q35161241 | Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin? |
| Q58867985 | Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation |
| Q37176340 | Metabolic Syndrome and Chronic Laryngitis: The Korean National Health and Nutrition Examination Survey 2008 to 2010 |
| Q37362881 | Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran |
| Q40202608 | Metabolic Syndrome and Lower Urinary Tract Symptoms: Epidemiological Study |
| Q53810275 | Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome? |
| Q53687232 | Metabolic Syndrome and Neuroprotection. |
| Q91962418 | Metabolic Syndrome and Salt-Sensitive Hypertension in Polygenic Obese TALLYHO/JngJ Mice: Role of Na/K-ATPase Signaling |
| Q91868008 | Metabolic Syndrome and Skin Diseases |
| Q89126800 | Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury |
| Q56928482 | Metabolic Syndrome as a Predictor for Postoperative Complications After Urologic Surgery |
| Q38690801 | Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance |
| Q40916334 | Metabolic Syndrome is Associated with Increased Postoperative Morbidity and Hospital Resource Utilization in Patients Undergoing Elective Pancreatectomy |
| Q36049231 | Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey |
| Q28212410 | Metabolic abnormalities and risk for colorectal cancer in the physicians' health study |
| Q37924816 | Metabolic alterations and chronic hepatitis C: treatment strategies |
| Q36121702 | Metabolic and Body Composition Risk Factors Associated with Metabolic Syndrome in a Cohort of Women with a High Prevalence of Cardiometabolic Disease |
| Q38643942 | Metabolic biomarkers and gallstone disease - a population-based study |
| Q34798951 | Metabolic changes and serum ghrelin level in patients with psoriasis. |
| Q33910549 | Metabolic characteristics of individuals at a high risk of type 2 diabetes - a comparative cross-sectional study |
| Q54215758 | Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk. |
| Q64936073 | Metabolic impairments in patients with myotonic dystrophy type 2. |
| Q92051284 | Metabolic issues in people with epilepsy |
| Q46032053 | Metabolic links between diabetes and Alzheimer's disease. |
| Q36842641 | Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes |
| Q47668348 | Metabolic risk factors and arterial stiffness in Indian children of parents with metabolic syndrome |
| Q87024850 | Metabolic risk factors and masked hypertension in the general population: the Finn-Home study |
| Q45143067 | Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults |
| Q43691248 | Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial |
| Q35890114 | Metabolic syndrome among obese Qataris attending primary health care centers in Doha, 2010. |
| Q35365361 | Metabolic syndrome among patients receiving clozapine: A preliminary estimate |
| Q51372559 | Metabolic syndrome and acute hyperglycemia are associated with endoplasmic reticulum stress in human mononuclear cells. |
| Q38137667 | Metabolic syndrome and associated chronic kidney diseases: nutritional interventions |
| Q34403580 | Metabolic syndrome and breast cancer: is there a link? |
| Q60305925 | Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase |
| Q44862707 | Metabolic syndrome and cardiovascular diseases in HIV patients |
| Q34606875 | Metabolic syndrome and cardiovascular risk |
| Q37400542 | Metabolic syndrome and central obesity in depression: A cross-sectional study |
| Q33762342 | Metabolic syndrome and chronic kidney disease |
| Q36498733 | Metabolic syndrome and dementia risk in a multiethnic elderly cohort |
| Q37383906 | Metabolic syndrome and disability: findings from the prospective three-city study |
| Q57559362 | Metabolic syndrome and endometrial cancer risk |
| Q34992352 | Metabolic syndrome and gastro-esophageal reflux: A link towards a growing interest in developed countries |
| Q34131461 | Metabolic syndrome and hemoglobin levels in elderly adults: the Invecchiare in Chianti Study |
| Q40565285 | Metabolic syndrome and its associated early-life factors in children and adolescents: a cross-sectional study in Guangzhou, China |
| Q36110664 | Metabolic syndrome and its components associated with chronic kidney disease. |
| Q35684189 | Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients |
| Q36686320 | Metabolic syndrome and its correlated factors in an urban population in South West of Iran. |
| Q43727420 | Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study |
| Q33939271 | Metabolic syndrome and localization of white matter hyperintensities in the elderly population |
| Q36451152 | Metabolic syndrome and nephrolithiasis |
| Q38682089 | Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation |
| Q26748989 | Metabolic syndrome and obesity in peritoneal dialysis |
| Q34718421 | Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. |
| Q37545143 | Metabolic syndrome and periodontitis: is oxidative stress a common link? |
| Q33401115 | Metabolic syndrome and physical activity in southern Brazilian community-dwelling elders: a population-based, cross-sectional study |
| Q38189473 | Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. |
| Q35172464 | Metabolic syndrome and prediabetes in ndokwa community of Nigeria: preliminary study |
| Q57476912 | Metabolic syndrome and psychiatric disorders: a population-based study |
| Q48469995 | Metabolic syndrome and quality of life in the elderly: age and gender differences. |
| Q44676240 | Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). |
| Q46132793 | Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT). |
| Q37413310 | Metabolic syndrome and risk of subsequent colorectal cancer |
| Q33655300 | Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study |
| Q57491169 | Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studies |
| Q50350856 | Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients. |
| Q88289276 | Metabolic syndrome as a risk indicator for periodontal disease and tooth loss |
| Q34948205 | Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score |
| Q35752040 | Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions |
| Q51283958 | Metabolic syndrome in drug-nave Chinese patients with insulin-sensitive and insulin-resistant type 2 diabetes. |
| Q35810417 | Metabolic syndrome in estonia: prevalence and associations with insulin resistance |
| Q44508389 | Metabolic syndrome in heart transplantation: impact on survival and renal function. |
| Q40890622 | Metabolic syndrome in infertile women with polycystic ovarian syndrome. |
| Q38044776 | Metabolic syndrome in patients with hematological diseases. |
| Q36897095 | Metabolic syndrome in patients with psoriatic disease. |
| Q36657453 | Metabolic syndrome in patients with severe mental illness in Gorgan |
| Q35573741 | Metabolic syndrome in peritoneal dialysis patients |
| Q46592462 | Metabolic syndrome in permanent night workers |
| Q38805127 | Metabolic syndrome in prostate cancer: impact on risk and outcomes |
| Q50127587 | Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study. |
| Q37102229 | Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients |
| Q51366559 | Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India. |
| Q42972164 | Metabolic syndrome in the 1982 Pelotas cohort: effect of contemporary lifestyle and socioeconomic status |
| Q46937434 | Metabolic syndrome in youth: a cross-sectional school-based survey. |
| Q38051221 | Metabolic syndrome in youth: chimera or useful concept? |
| Q36996559 | Metabolic syndrome in youths |
| Q46801064 | Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats |
| Q39240024 | Metabolic syndrome increases the prevalence of spine osteoarthritis |
| Q48567278 | Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. |
| Q90115703 | Metabolic syndrome is a risk factor for colorectal adenoma and cancer: a study in a White population using the harmonized criteria |
| Q51781353 | Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. |
| Q44531125 | Metabolic syndrome is associated with impaired health-related quality of life: Lapinlahti 2005 study |
| Q42853726 | Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study |
| Q36121965 | Metabolic syndrome is associated with self-perceived depression |
| Q35638342 | Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study |
| Q37374394 | Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease |
| Q48227537 | Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. |
| Q36560427 | Metabolic syndrome model definitions predicting type 2 diabetes and cardiovascular disease |
| Q36829065 | Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults |
| Q46905060 | Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. |
| Q35195226 | Metabolic syndrome, aging and involvement of oxidative stress |
| Q37417693 | Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis |
| Q34595173 | Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. |
| Q41139603 | Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort |
| Q36292440 | Metabolic syndrome, endothelial dysfunction, and erectile dysfunction: association and management |
| Q28219348 | Metabolic syndrome, inflammation and atherosclerosis |
| Q26782663 | Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links |
| Q34262473 | Metabolic syndrome, its components, and mortality in the elderly |
| Q57814780 | Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women |
| Q89536138 | Metabolic syndrome: The Indian public health perspective |
| Q37982204 | Metabolic syndrome: definition and therapeutic implications |
| Q35047747 | Metabolic syndrome: definitions and controversies. |
| Q33691139 | Metabolic syndrome: from epidemiology to systems biology |
| Q33796880 | Metabolic syndrome: is equine disease comparable to what we know in humans? |
| Q36338139 | Metabolically healthy obesity and depressive symptoms: 16-year follow-up of the Gazel cohort study |
| Q35132725 | Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study |
| Q34321895 | Metabolism and the circadian clock converge |
| Q34922762 | Metabolism, genomics, and DNA repair in the mouse aging liver |
| Q92776030 | Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain |
| Q39225251 | Metformin Reduces Lipogenesis Markers in Obese Mice Fed a Low-Carbohydrate and High-Fat Diet |
| Q43299787 | Metformin effects upon blood pressure and glucose metabolism of monossodium glutamate induced-obese spontaneously hypertensive rats |
| Q37855307 | Metformin in prostate cancer: two for the price of one. |
| Q28472548 | Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1 |
| Q43206333 | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells |
| Q35070980 | MicroRNA-494, upregulated by tumor necrosis factor-α, desensitizes insulin effect in C2C12 muscle cells |
| Q46987592 | Microalbuminuria and the metabolic syndrome and its components in the Chinese population |
| Q38754079 | Microalgae Nutraceuticals |
| Q91582158 | Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice |
| Q47097027 | Microparticles Carrying Peroxisome Proliferator-Activated Receptor Alpha Restore the Reduced Differentiation and Functionality of Bone Marrow-Derived Cells Induced by High-Fat Diet. |
| Q42133190 | Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy |
| Q94544646 | Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing's Syndrome |
| Q36735624 | Milk and the metabolic syndrome |
| Q36988174 | Milk protein for improved metabolic health: a review of the evidence |
| Q36942788 | Mitochondrial dysfunction in metabolic syndrome and asthma |
| Q27022800 | Mitochondrial genetics and obesity: evolutionary adaptation and contemporary disease susceptibility |
| Q36109269 | Mitoflash altered by metabolic stress in insulin-resistant skeletal muscle |
| Q36699198 | Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats |
| Q51766064 | Model-based recursive partitioning to identify risk clusters for metabolic syndrome and its components: findings from the International Mobility in Aging Study. |
| Q44259841 | Modeling metabolic syndrome through structural equations of metabolic traits, comorbid diseases, and GWAS variants. |
| Q38086043 | Modeling obesity and its associated disorders in Drosophila |
| Q38948892 | Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments. |
| Q27024434 | Modelling age-related metabolic disorders in the mouse |
| Q57470488 | Moderate coffee consumption is inversely associated with the metabolic syndrome in the Korean adult population |
| Q41608719 | Moderate red wine consumption is associated with a lower prevalence of the metabolic syndrome in the PREDIMED population |
| Q91411487 | Modern-day environmental factors in the pathogenesis of osteoarthritis |
| Q46977851 | Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis |
| Q38991475 | Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients |
| Q34760466 | Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. |
| Q33695218 | Modulation of the Gut Microbiota by Krill Oil in Mice Fed a High-Sugar High-Fat Diet |
| Q44364073 | Modulatory effects of yerba maté (Ilex paraguariensis) on the PI3K-AKT signaling pathway |
| Q64237035 | Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes |
| Q38312460 | Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists |
| Q36046731 | Mortal quintet of sickle cell diseases. |
| Q41584436 | Multi-Targeted Molecular Effects of Hibiscus sabdariffa Polyphenols: An Opportunity for a Global Approach to Obesity |
| Q34185797 | Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis |
| Q45145219 | Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance. |
| Q35201538 | N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters |
| Q91844305 | N1-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation |
| Q80964439 | NASH predicts plasma inflammatory biomarkers independently of visceral fat in men |
| Q92579507 | Nanoformulations of natural products for management of metabolic syndrome |
| Q24648189 | Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance |
| Q36195561 | National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease? |
| Q36190718 | Natural killer T cells in adipose tissue prevent insulin resistance |
| Q47587165 | Neck circumference: A valuable anthropometric measurement to detect metabolic syndrome among different age groups in China. |
| Q36250333 | Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study |
| Q41927293 | Nerium oleander Distillate Improves Fat and Glucose Metabolism in High-Fat Diet-Fed Streptozotocin-Induced Diabetic Rats |
| Q39090626 | Neural regulation of immunity: molecular mechanisms and clinical translation. |
| Q26752744 | Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome |
| Q31031047 | Neuron-Glia Crosstalk in the Autonomic Nervous System and Its Possible Role in the Progression of Metabolic Syndrome: A New Hypothesis |
| Q90380337 | New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease |
| Q37288741 | New drugs for type 2 diabetes mellitus: what is their place in therapy? |
| Q38397340 | New perspectives on the development of antiobesity drugs |
| Q38127652 | Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis |
| Q45914438 | Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation. |
| Q35022734 | No Improvement in Metabolic Health Condition of 40-74-year-old Rural Residents One Year After Screening |
| Q37905816 | No time to 'weight': the link between obesity and stroke in women |
| Q36399368 | Non-Alcoholic Fatty Liver Disease, a Marker of Subclinical Atherosclerosis Applicable Only to Metabolic Syndrome?: Time to Organize the Connection between Metabolism and Atherosclerosis |
| Q37847587 | Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment |
| Q46287704 | Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. |
| Q64231089 | Nonalcoholic Fatty Liver Disease Aggravated the Severity of Acute Pancreatitis in Patients |
| Q90294597 | Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature |
| Q35678746 | Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. |
| Q37318761 | Nonalcoholic fatty liver disease and cardiovascular risk |
| Q46689926 | Nonalcoholic fatty liver disease and carotid atherosclerosis in children |
| Q37140029 | Nonalcoholic fatty liver disease as a component of the metabolic syndrome |
| Q37316685 | Nonalcoholic fatty liver disease is associated with coronary artery calcification. |
| Q51550409 | Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. |
| Q39892915 | Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease |
| Q46959415 | Normalization of metabolic syndrome using fenofibrate, metformin or their combination |
| Q36079508 | Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders |
| Q47692391 | Novel Insights in the Metabolic Syndrome in Childhood and Adolescence |
| Q96129205 | Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome |
| Q38374396 | Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease |
| Q33699001 | Nuclear receptors, mitochondria and lipid metabolism |
| Q48276918 | Nutrient-Derived Dietary Patterns and Their Association With Metabolic Syndrome in a Japanese Population |
| Q90447037 | Nutrients in Fish and Possible Associations with Cardiovascular Disease Risk Factors in Metabolic Syndrome |
| Q36607644 | Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. |
| Q36083434 | Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease |
| Q92874410 | Nutritional Challenges in Metabolic Syndrome |
| Q35094103 | Nutritional Status Associated with Metabolic Syndrome in Middle-School Children in the City of Montes Claros - MG, Brazil |
| Q37662881 | Obese and diabetic KKAy mice show increased mortality but improved cardiac function following myocardial infarction. |
| Q94526018 | Obesity Indices for Identifying Metabolic Syndrome Among Type Two Diabetes Patients Attending Their Follow-Up in Dessie Referral Hospital, North east Ethiopia |
| Q22241931 | Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss |
| Q26824442 | Obesity and african americans: physiologic and behavioral pathways |
| Q56988184 | Obesity and cancer |
| Q81369519 | Obesity and cardiovascular disease |
| Q36918336 | Obesity and gastrointestinal diseases |
| Q46936586 | Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. |
| Q47850975 | Obesity and metabolic syndrome in COPD: is exercise the answer? |
| Q35032218 | Obesity and periodontal disease |
| Q37685290 | Obesity and shift work: chronobiological aspects. |
| Q37133415 | Obesity and the gut microbiome: Striving for causality. |
| Q37618246 | Obesity and the hypertensive disorders of pregnancy. |
| Q36995540 | Obesity and vascular dysfunction. |
| Q47439042 | Obesity as a disease state: a new paradigm for diagnosis and treatment |
| Q36879686 | Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review |
| Q97524380 | Obesity preventive function of novel edible mushroom, Basidiomycetes-X (Echigoshirayukidake): Manipulations of insulin resistance and lipid metabolism |
| Q36219761 | Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging: Atherosclerosis Risk in Communities Study |
| Q35200808 | Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease |
| Q36798998 | Obesity, inflammation, and periodontal disease |
| Q38186327 | Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment |
| Q38656281 | Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia |
| Q37944926 | Obesity, obstructive sleep apnoea and metabolic syndrome |
| Q46036629 | Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver. |
| Q64108091 | Obesity-Related Epigenetic Changes After Bariatric Surgery |
| Q37323375 | Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. |
| Q30243992 | Obesity: Current and potential pharmacotherapeutics and targets |
| Q34114095 | Obesity: how to define central adiposity? |
| Q60308237 | Observational study of the status of coronary risk biomarkers among Negritos with metabolic syndrome in the east coast of Malaysia |
| Q37294284 | Obstructive sleep apnea and metabolic syndrome in spanish population |
| Q48282410 | Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: the SYNAPSE cohort. |
| Q43061638 | Obstructive sleep apnea and the metabolic syndrome. |
| Q35104040 | Obstructive sleep apnea, inflammation, and the metabolic syndrome |
| Q46270693 | Occupational Exposures and Metabolic Syndrome Among Hispanics/Latinos: Cross-Sectional Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). |
| Q97417142 | Occupational distribution of metabolic syndrome prevalence and incidence differs by sex and is not explained by age and health behavior: results from 75 000 Dutch workers from 40 occupational groups |
| Q44790679 | Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone? |
| Q58886456 | On Patient’s Characteristics Extraction for Metabolic Syndrome Diagnosis: Predictive Modelling Based on Machine Learning |
| Q82368010 | On the association between soft drink consumption and Helicobacter pylori infection |
| Q36632433 | Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity? |
| Q59335943 | Optimal cut-off for obesity and markers of metabolic syndrome for Ethiopian adults |
| Q37060883 | Optimal cut-off levels of obesity indices by different definitions of metabolic syndrome in a southeast rural Chinese population |
| Q33558441 | Optimal cut-off point of waist circumference for the diagnosis of metabolic syndrome in Japanese subjects |
| Q37083329 | Optimizing management of metabolic syndrome to reduce risk: focus on life-style. |
| Q45060908 | Oral contraceptive use and measurable cardiovascular risk factors in Korean women aged 20-50 years: the Fourth Korean National Health and Nutrition Examination Survey 2007-2009 (KNHANES IV). |
| Q43879860 | Organophosphorus insecticide, monocrotophos, possesses the propensity to induce insulin resistance in rats on chronic exposure |
| Q36529528 | Orphan nuclear receptors: therapeutic opportunities in skeletal muscle. |
| Q42831905 | Over-expression of AQP7 contributes to improve insulin resistance in adipocytes |
| Q34237337 | Overall diet history and reversibility of the metabolic syndrome over 5 years: the Whitehall II prospective cohort study |
| Q38046539 | Overlapped metabolic and therapeutic links between Alzheimer and diabetes. |
| Q36937221 | Overviews of pathogen emergence: which pathogens emerge, when and why? |
| Q84595605 | Overweight and obesity: the pathogenesis of cardiometabolic risk |
| Q46501907 | Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome |
| Q37883706 | Oxidative tissue: perilipin 5 links storage with the furnace |
| Q35129333 | Ozone induces glucose intolerance and systemic metabolic effects in young and aged Brown Norway rats |
| Q37581408 | PDE5 inhibitors for LUTS. |
| Q37346326 | PGC-1alpha in aging and anti-aging interventions |
| Q90671739 | PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism |
| Q24541527 | PPAR delta: a dagger in the heart of the metabolic syndrome |
| Q36426786 | PPAR-gamma in the Cardiovascular System |
| Q38674742 | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. |
| Q35235884 | PPARγ population shift produces disease-related changes in molecular networks associated with metabolic syndrome. |
| Q39146765 | PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. |
| Q36006224 | Paediatric obesity research in early childhood and the primary care setting: the TARGet Kids! research network |
| Q30278852 | Palatability Can Drive Feeding Independent of AgRP Neurons |
| Q52727877 | Palmitate and minimally-modified low-density lipoprotein cooperatively promote inflammatory responses in macrophages. |
| Q42235606 | Palmitoleate inhibits insulin transcription by activating the ERK1/2 pathway in rat pancreatic β-cells |
| Q42110957 | Paprika Pigments Attenuate Obesity-Induced Inflammation in 3T3-L1 Adipocytes. |
| Q48252102 | Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity. |
| Q55084158 | Paraoxonase activity in metabolic syndrome in children and adolescents. |
| Q42598623 | Parity and the metabolic syndrome in older Chinese women: the Guangzhou Biobank Cohort Study. |
| Q36073974 | Partially hydrolyzed guar gum affects the expression of genes involved in host defense functions and cholesterol absorption in colonic mucosa of db/db male mice |
| Q46051147 | Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue |
| Q36031314 | Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. |
| Q37095682 | Pathomechanisms of nephrolithiasis |
| Q33359627 | Pathophysiological, genetic and gene expression features of a novel rodent model of the cardio-metabolic syndrome |
| Q55259516 | Pathophysiology of Metabolic Syndrome. |
| Q27022707 | Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis |
| Q30248402 | Pathophysiology-based treatment of urolithiasis. |
| Q39534108 | Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management |
| Q41844897 | Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology |
| Q44739068 | Pericardial fat amount is an independent risk factor of coronary artery stenosis assessed by multidetector-row computed tomography: the Korean Atherosclerosis Study 2. |
| Q27012460 | Periconception weight loss: common sense for mothers, but what about for babies? |
| Q40323104 | Perinatal and childhood origins of cardiovascular disease. |
| Q35109379 | Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes |
| Q44983160 | Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury |
| Q55280437 | Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle. |
| Q38633502 | Peroxisome proliferator-activated receptors and hepatitis C virus |
| Q41457655 | Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. |
| Q28488272 | Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice |
| Q39295819 | Personality profiles and health: longitudinal evidence among Finnish adults |
| Q46046912 | Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials. |
| Q43478611 | Pharmacological evaluation of a β-hydroxyphosphonate analogue of l-carnitine in obese Zucker fa/fa rats. |
| Q36130309 | Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation. |
| Q90659770 | Phenotyping diabetic cardiomyopathy in Europeans and South Asians |
| Q42135510 | Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice |
| Q79258772 | Physical activity and cardiovascular risk in children |
| Q37273684 | Physical activity and prevention of type 2 diabetes mellitus |
| Q33489061 | Physical activity and risk of metabolic syndrome in an urban Mexican cohort. |
| Q35124767 | Physical activity patterns and metabolic syndrome in Costa Rica |
| Q92830898 | Physical activity, sedentary time and their associations with clustered metabolic risk among people with type 2 diabetes in Jiangsu province: a cross-sectional study |
| Q41840718 | Physical training improves body weight and energy balance but does not protect against hepatic steatosis in obese mice |
| Q92444770 | Physiological and Metabolic Effects of Yellow Mangosteen (Garcinia dulcis) Rind in Rats with Diet-Induced Metabolic Syndrome |
| Q40076014 | Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice |
| Q40262958 | Pioglitazone induces apoptosis of macrophages in human adipose tissue |
| Q92630572 | Pistachio Consumption Alleviates Inflammation and Improves Gut Microbiota Composition in Mice Fed a High-Fat Diet |
| Q33881452 | Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program |
| Q35230438 | Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana |
| Q44354378 | Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland health study |
| Q51344617 | Plasma concentration of soluble intercellular adhesion molecule-1 (sICAM-1) is elevated in type 2 diabetic patients, and sICAM-1 synthesis is associated with leptin-induced activation of the mitogen-activated protein kinase (MAPK) pathway. |
| Q35886266 | Plasma diacylglycerol composition is a biomarker of metabolic syndrome onset in rhesus monkeys. |
| Q34668850 | Plasma fatty acids and the risk of metabolic syndrome in ethnic Chinese adults in Taiwan |
| Q36471741 | Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway |
| Q39508482 | Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. |
| Q46832264 | Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome |
| Q36656492 | Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance |
| Q43224142 | Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan |
| Q35906917 | Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects. |
| Q39253299 | Platelet count can predict metabolic syndrome in older women |
| Q34005816 | Pleiotropic genes for metabolic syndrome and inflammation |
| Q38081061 | Pleiotropic preventive effects of dietary polyphenols in cardiovascular diseases |
| Q51327862 | Poor breakfast habits in adolescence predict the metabolic syndrome in adulthood. |
| Q38900562 | Population health and Mediterranean diet in southern Mediterranean countries |
| Q30372054 | Population-based metabolic syndrome risk score and its determinants: The Isfahan Healthy Heart Program. |
| Q37996593 | Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview |
| Q40964527 | Porphyromonas gingivalis Suppresses Differentiation and Increases Apoptosis of Osteoblasts From New Zealand Obese Mice |
| Q51487360 | Postchallenge glucose rises with increasing age even when glucose tolerance is normal. |
| Q33932584 | Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial |
| Q46074170 | Power of biomarkers and their relative contributions to metabolic syndrome in Slovak adult women. |
| Q51286746 | Predicting Metabolic Syndrome Using the Random Forest Method. |
| Q41923652 | Predicting the occurrence of cancer-associated colorectal polyp using a metabolic risk score |
| Q44510345 | Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases |
| Q35612772 | Predictive Power for Type 2 Diabetes Mellitus using Dynamic Change of Metabolic Syndrome, Dynamic Change of Fasting Plasma Glucose, Metabolic Syndrome and Fasting Plasma Glucose |
| Q37028898 | Predictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome |
| Q85758512 | Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study |
| Q33876859 | Predictors of healthcare professionals' intention and behaviour to encourage physical activity in patients with cardiovascular risk factors |
| Q33844747 | Predictors of obstructive sleep apnea in males with metabolic syndrome |
| Q37187346 | Prescription n-3 fatty acids, but not eicosapentaenoic acid alone, improve reference memory-related learning ability by increasing brain-derived neurotrophic factor levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model |
| Q51246650 | Prevalence Risk of Metabolic Syndrome Associated with Alcohol Use Behavior in Korean Women. |
| Q44636613 | Prevalence and associated factors for metabolic syndrome in Taiwanese hospital employees. |
| Q45713421 | Prevalence and factors associated with dyslipidemia after liver transplantation |
| Q94468739 | Prevalence and factors associated with overweight and central obesity among adults in the Eastern Sudan |
| Q34354248 | Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. |
| Q36227785 | Prevalence of Diabetes and Associated Factors in the Uyghur and Han Population in Xinjiang, China |
| Q90011997 | Prevalence of ECG abnormalities among adults with metabolic syndrome in a Nigerian Teaching Hospital |
| Q30234373 | Prevalence of Metabolic Syndrome among Iranian Population: A Systematic Review and Meta-analysis |
| Q37373760 | Prevalence of Metabolic Syndrome among Korean Adolescents According to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation |
| Q38648830 | Prevalence of Metabolic Syndrome among Psychiatric Inpatients: A Hospital Based Study from Kashmir |
| Q64272812 | Prevalence of Metabolic Syndrome and Associated Risk Factors among Men in a Rural Health Centre Area in Tamil Nadu |
| Q37154282 | Prevalence of Metabolic Syndrome and Its Clinical and Angiographic Profile in Patients With Naive Acute Coronary Syndrome in North Indian Population |
| Q47578175 | Prevalence of Metabolic Syndrome and Its Individual Components Among Midwestern University Students |
| Q41582154 | Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case-Control Study |
| Q37589478 | Prevalence of Metabolic Syndrome in Patients with Schizophrenia in Korea: A Multicenter Nationwide Cross-Sectional Study |
| Q89677934 | Prevalence of and associations between metabolic syndrome and the constitutions defined by Korean Eight Constitution Medicine |
| Q42881671 | Prevalence of diabetes and associated factors in an urban adult population of low educational level and income from the Brazilian Northeast wilderness |
| Q39455653 | Prevalence of diabetes and obesity in association with prematurity and growth restriction |
| Q45227635 | Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome. |
| Q34985603 | Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal |
| Q91995276 | Prevalence of hyperuricemia and its association with metabolic syndrome and cardiometabolic risk factors in Korean children and adolescents: analysis based on the 2016-2017 Korea National Health and Nutrition Examination Survey |
| Q38916947 | Prevalence of metabolic abnormalities in the Tunisian adults: a population based study |
| Q33912265 | Prevalence of metabolic syndrome among adults with liver function injury in rural area of Southwest China: A cross-sectional study |
| Q40066816 | Prevalence of metabolic syndrome and associated risk factors in Brazilian schoolchildren. |
| Q44676405 | Prevalence of metabolic syndrome and its associated factors in a rural area of Minas Gerais State (MG, Brazil) |
| Q39991010 | Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study |
| Q39776827 | Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population |
| Q37011521 | Prevalence of metabolic syndrome and its risk factors in Canadian children and adolescents: Canadian Health Measures Survey Cycle 1 (2007-2009) and Cycle 2 (2009-2011) |
| Q38631346 | Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis |
| Q46042911 | Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. |
| Q39699441 | Prevalence of metabolic syndrome defined by the International Diabetes Federation and National Cholesterol Education Program criteria among Thai adults |
| Q36862288 | Prevalence of metabolic syndrome in 8-18-year-old school-going children of Srinagar city of Kashmir India |
| Q51745150 | Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. |
| Q33783840 | Prevalence of metabolic syndrome in COPD patients and its consequences |
| Q44775976 | Prevalence of metabolic syndrome in Galicia (NW Spain) on four alternative definitions and association with insulin resistance |
| Q39709268 | Prevalence of metabolic syndrome in Iran: A 2011 update |
| Q45053588 | Prevalence of metabolic syndrome in a semi-arid rural area in Bahia |
| Q36862175 | Prevalence of metabolic syndrome in adolescents aged 10-18 years in Jammu, J and K. |
| Q47958233 | Prevalence of metabolic syndrome in children aged 5-9 years from southwest colombia: a cross-sectional study. |
| Q46807792 | Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation |
| Q34992384 | Prevalence of metabolic syndrome in patients with minor beta thalassemia and its related factors: a cross-sectional study. |
| Q35753936 | Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom |
| Q47426775 | Prevalence of metabolic syndrome in rural elderly of Asian Indian origin |
| Q36647948 | Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India |
| Q36133365 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India |
| Q43087820 | Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population |
| Q33239514 | Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey |
| Q33520230 | Prevalence of physical inactivity in nine rural INDEPTH Health and Demographic Surveillance Systems in five Asian countries |
| Q34306717 | Prevalence of risk factors for the metabolic syndrome in the middle income Caribbean nation of st. Lucia |
| Q34120737 | Prevalence of the metabolic syndrome among children from six cities of China |
| Q37646606 | Prevalence of the metabolic syndrome and determination of optimal cut-off values of waist circumference in university employees from Angola |
| Q30396880 | Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study |
| Q38302430 | Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria |
| Q34146740 | Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study |
| Q36568261 | Prevalence of the metabolic syndrome using two proposed definitions in a Japanese-Brazilians community |
| Q35748660 | Prevalence, components, and correlates of metabolic syndrome (MetS) among elderly Muscovites |
| Q35360398 | Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release |
| Q37157079 | Prevention of type 2 diabetes mellitus with angiotensin-converting-enzyme inhibitors |
| Q34646512 | Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review |
| Q46494646 | Prioritization of candidate disease genes for metabolic syndrome by computational analysis of its defining phenotypes |
| Q37718514 | Procedure and outcomes of Roux-en-Y gastric bypass |
| Q64093518 | Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease the modulation of the gut microbiota in rabbits |
| Q36633228 | Profile of Free Fatty Acids and Fractions of Phospholipids, Cholesterol Esters and Triglycerides in Serum of Obese Youth with and without Metabolic Syndrome. |
| Q58209743 | Progression to impaired glucose regulation, diabetes and metabolic syndrome in Chinese women with a past history of gestational diabetes |
| Q42485242 | Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction |
| Q39111702 | Prospective associations between ambulatory activity, body composition and muscle function in older adults. |
| Q36868309 | Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study |
| Q36840608 | Prospectively measured lifestyle factors and BMI explain differences in health-related quality of life between colorectal cancer patients with and without comorbid diabetes. |
| Q53146297 | Protective actions of globular and full-length adiponectin on human endothelial cells: novel insights into adiponectin-induced angiogenesis. |
| Q35670457 | Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. |
| Q52741486 | Proteomics of Children Born After Intracytoplasmic Sperm Injection Reveal Indices of an Adverse Cardiometabolic Profile. |
| Q34547857 | Proteomics reveals the effects of sustained weight loss on the human plasma proteome |
| Q35564637 | Psoriasis and increased prevalence of hypertension and diabetes mellitus |
| Q37743164 | Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions |
| Q34777002 | Psoriasis and the risk of pneumonia: a population-based study |
| Q35168945 | Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature |
| Q37084274 | Psoriasis comorbidities |
| Q51430304 | Psychosocial status and health related quality of life in relation to the metabolic syndrome in a Swedish middle-aged population. |
| Q35354217 | QRS fragmentation and sudden cardiac death in the obese and overweight |
| Q37601122 | Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. |
| Q30677112 | Quantitative proton MR techniques for measuring fat |
| Q39363428 | Quantity and quality of nocturnal sleep affect morning glucose measurement in acutely burned children |
| Q46542331 | Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats |
| Q33574498 | RETRACTED: Leisure-time physical activity and the risk of metabolic syndrome: meta-analysis |
| Q95406381 | Radiotherapy toxicity |
| Q33815547 | Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort). |
| Q36105361 | Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort). |
| Q46533509 | Rapid dose-dependent effect of clozapine on a schizophrenic patient's lipid profile |
| Q46526819 | Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men. |
| Q50551596 | Rats Fed a Diet Rich in Fats and Sugars Are Impaired in the Use of Spatial Geometry. |
| Q34936316 | Recent advances in the pathophysiology of nephrolithiasis |
| Q57821646 | Recent advances in understanding and managing cholesterol gallstones |
| Q47704338 | Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: An analysis of the NHANES surveys from 1999 to 2014. |
| Q30874878 | Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men. |
| Q27345199 | Red Blood Cells from Individuals with Abdominal Obesity or Metabolic Abnormalities Exhibit Less Deformability upon Entering a Constriction. |
| Q35849602 | Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients. |
| Q37244563 | Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B. |
| Q34208250 | Reducing plasma membrane sphingomyelin increases insulin sensitivity |
| Q53145955 | Reevaluating the diagnostic criteria for metabolic syndrome in the Taiwanese population. |
| Q37076473 | Regulation of signal transduction by HDL. |
| Q52684606 | Relation of Waist-Hip Ratio to Long-Term Cardiovascular Events in Patients With Coronary Artery Disease. |
| Q41580061 | Relation of metabolic syndrome with endometrial pathologies in patients with abnormal uterine bleeding |
| Q43511876 | Relation of periodontitis and metabolic syndrome with gestational glucose metabolism disorder. |
| Q41587365 | Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia |
| Q64262354 | Relationship Between the Neutrophil to Lymphocyte Ratio and the Presence and Size of Thyroid Nodules |
| Q64093563 | Relationship between Resistin, Endothelin-1, and Flow-Mediated Dilation in Patient with and without Metabolic Syndrome |
| Q36069753 | Relationship between adipose tissue lipolytic activity and skeletal muscle insulin resistance in nondiabetic women |
| Q48021372 | Relationship between family history of type 2 diabetes and serum FGF21. |
| Q36411940 | Relationship between hOGG1 Ser326Cys gene polymorphism and coronary artery lesions in patients with diabetes mellitus |
| Q43176618 | Relationship between insulin and hypogonadism in men with metabolic syndrome |
| Q36461174 | Relationship between metabolic syndrome and thyroid nodules in healthy Koreans |
| Q43132412 | Relationship between number of metabolic syndrome components and dietary factors in middle-aged and elderly Japanese subjects |
| Q35419743 | Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010. |
| Q34114420 | Relationship between the Prevalence of Thyroid Nodules and Metabolic Syndrome in the Iodine-Adequate Area of Hangzhou, China: A Cross-Sectional and Cohort Study |
| Q43191179 | Relationship between the percentage of predicted cardiorespiratory fitness and cardiovascular disease risk factors in premenopausal women: a MONET study |
| Q36685502 | Relationship between waist circumference, visceral fat and metabolic syndrome in a Congolese community: further research is still to be undertaken |
| Q98289183 | Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes |
| Q51647017 | Relationship of metabolic syndrome to chronic periodontitis. |
| Q37141711 | Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q36794045 | Relationship of physical activity to cardiovascular risk factors in an urban population of Nigerian adults |
| Q37446959 | Relationships between FTO rs9939609, MC4R rs17782313, and PPARγ rs1801282 polymorphisms and the occurrence of selected metabolic and hormonal disorders in middle-aged and elderly men - a preliminary study. |
| Q61799509 | Relationships between Vitamin D₃ and Metabolic Syndrome |
| Q34589466 | Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus |
| Q55207928 | Relative handgrip strength as a marker of metabolic syndrome: the Korea National Health and Nutrition Examination Survey (KNHANES) VI (2014-2015). |
| Q50492652 | Renal distribution of ganglioside GM3 in rat models of types 1 and 2 diabetes. |
| Q36877530 | Resistance to diet-induced obesity in mice with a single substituted chromosome |
| Q37799756 | Resistant hypertension in the high-risk metabolic patient |
| Q84618182 | Resistin level is positively correlated with thrombotic complications in Southern Chinese metabolic syndrome patients |
| Q37584891 | Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity |
| Q54503107 | Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. |
| Q42848227 | Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome |
| Q36339075 | Resveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome. |
| Q33946318 | Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone |
| Q51344561 | Retinol-binding protein 4 as a risk factor for cholesterol gallstone formation. |
| Q38202220 | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. |
| Q49723467 | Revisiting the metabolic syndrome: the emerging role of aquaglyceroporins. |
| Q37598000 | Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report |
| Q38236740 | Rheumatoid arthritis and metabolic syndrome |
| Q34108896 | Right ventricle free wall mechanics in metabolic syndrome without type-2 diabetes: effects of a 3-month lifestyle intervention program |
| Q46720321 | Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing |
| Q51733226 | Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. |
| Q50787843 | Risk factors for metabolic syndrome in stable Italian renal transplant patients. |
| Q38877264 | Risk factors of post-operative severe hyperlactatemia and lactic acidosis following laparoscopic resection for pheochromocytoma. |
| Q90460940 | Risk of Cardiovascular Disease Related to Metabolic Syndrome in College Students: A Cross-Sectional Secondary Data Analysis |
| Q90038845 | Risk of coronary heart disease in the rural population in Xinjiang: A nested case-control study in China |
| Q33788524 | Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome |
| Q38813011 | Role of E3 ubiquitin ligases in insulin resistance |
| Q48228971 | Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms. |
| Q38256054 | Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit. |
| Q26824127 | Role of leptin resistance in the development of obesity in older patients |
| Q33938800 | Role of metabolic syndrome components in human immunodeficiency virus-associated stroke |
| Q36567326 | Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome |
| Q45357892 | Role of omentin-1 and C-reactive protein in obese subjects with subclinical inflammation. |
| Q54197661 | Role of physicochemical properties in the activation of peroxisome proliferator-activated receptor δ. |
| Q35113885 | Role of the Renin-Angiotensin system and aldosterone on cardiometabolic syndrome |
| Q37737495 | Role of urotensin II in health and disease |
| Q34142923 | Roles of dietary inorganic nitrate in cardiovascular health and disease. |
| Q37281728 | SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction |
| Q39364708 | SES Gradients Among Mexicans in the United States and in Mexico: A New Twist to the Hispanic Paradox? |
| Q36133821 | SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study |
| Q36479802 | SIRT1 and energy metabolism |
| Q33588790 | SIRT1 performs a balancing act on the tight-rope toward longevity |
| Q36140230 | Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial |
| Q35846190 | Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway. |
| Q40085114 | Salivary extracellular RNA biomarkers for insulin resistance detection in hispanics |
| Q41447207 | Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice |
| Q37097161 | Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease |
| Q47877921 | Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort |
| Q38130122 | Seaweeds as potential therapeutic interventions for the metabolic syndrome |
| Q27318194 | Secretion and signaling activities of lipoprotein-associated hedgehog and non-sterol-modified hedgehog in flies and mammals |
| Q90449792 | Sepsis Patients in Critical Care Units with Obesity: Is Obesity Protective? |
| Q59100604 | Sequence variants of ADIPOQ and association with type 2 diabetes mellitus in Taiwan Chinese Han population |
| Q57300398 | Serum Matrix Metalloproteinase 9 and Macrophage Migration Inhibitory Factor (MIF) Are Increased in Young Healthy Nonobese Subjects with Positive Family History of Type 2 Diabetes |
| Q91946720 | Serum Uric Acid and Metabolic Syndrome: a Retrospective Cohort Study |
| Q34446808 | Serum ferritin levels and the development of metabolic syndrome and its components: a 6.5-year follow-up study |
| Q34992896 | Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults. |
| Q33771181 | Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease |
| Q37105317 | Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue |
| Q46849188 | Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes |
| Q36521917 | Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults |
| Q45966116 | Serum visfatin in Asian women with polycystic ovary syndrome. |
| Q55024308 | Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men. |
| Q55091259 | Sex Differences in the Prevalence and Modulators of Sleep-Disordered Breathing in Outpatients with Type 2 Diabetes. |
| Q57125019 | Sex differences in associations among metabolic syndrome, obesity, related biomarkers, and colorectal adenomatous polyp risk in a Japanese population |
| Q44299100 | Sex differences in the relationship between inflammatory and hemostatic biomarkers and metabolic syndrome: British 1958 Birth Cohort. |
| Q33941668 | Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controls. |
| Q34014004 | Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity |
| Q36343393 | Sex-specific increase in susceptibility to metabolic syndrome in adult offspring after prenatal ethanol exposure with post-weaning high-fat diet |
| Q33771378 | Sexual dimorphism in ratio of second and fourth digits and its relationship with metabolic syndrome indices and cardiovascular risk factors |
| Q36199313 | Shift work and health: current problems and preventive actions |
| Q36931409 | Short-term effects of moderate intensity physical activity in patients with metabolic syndrome |
| Q36646856 | Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial |
| Q47241002 | Short-term, high-fat overfeeding impairs glycaemic control but does not alter gut hormone responses to a mixed meal tolerance test in healthy, normal-weight individuals |
| Q46697313 | Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease |
| Q34415126 | Sickle cell diseases and ileus. |
| Q33725500 | Signaling through Tyr985 of leptin receptor as an age/diet-dependent switch in the regulation of energy balance |
| Q36427326 | Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study |
| Q35214969 | Sirtuin 1 in lipid metabolism and obesity |
| Q35636863 | Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II |
| Q46193261 | Six-month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus |
| Q36603044 | Skeletal intramyocellular lipid metabolism and insulin resistance |
| Q33742916 | Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components. |
| Q37351241 | Sleep Duration and Midday Napping with 5-Year Incidence and Reversion of Metabolic Syndrome in Middle-Aged and Older Chinese. |
| Q37229073 | Sleep and Glucose Intolerance/Diabetes Mellitus |
| Q34447701 | Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence |
| Q36965966 | Sleep, type 2 diabetes, dyslipidemia, and hypertension in elderly Alzheimer's caregivers |
| Q38256622 | Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome |
| Q61446050 | Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation |
| Q49537376 | Smoking Cessation without Educational Instruction could Promote the Development of Metabolic Syndrome. |
| Q36803836 | Sodium taste threshold in children and its relationship to blood pressure |
| Q37569775 | Soluble form of receptor for advanced glycation end products is associated with obesity and metabolic syndrome in adolescents. |
| Q57191051 | Soyasapogenols reduce cellular triglyceride levels in 3T3-L1 mouse adipocyte cells by accelerating triglyceride lipolysis |
| Q34607229 | Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia. |
| Q47138133 | Specific plasma amino acid disturbances associated with metabolic syndrome |
| Q24602803 | Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? |
| Q36411099 | Statins: another class of antihypertensive agents? |
| Q79222798 | Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro |
| Q42870806 | Steatosis as a co-factor in chronic liver diseases |
| Q47814091 | Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome |
| Q37194827 | Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men. |
| Q36825800 | Stress and Its Effects on Glucose Metabolism and 11β-HSD Activities in Rats Fed on a Combination of High-Fat and High-Sucrose Diet with Glycyrrhizic Acid |
| Q34377692 | Stress and eating behaviors |
| Q38074862 | Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective |
| Q39178149 | Stress, overeating, and obesity: Insights from human studies and preclinical models. |
| Q46884212 | Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children |
| Q46087369 | Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase. |
| Q34857638 | Study of Insulin Resistance in Subclinical Hypothyroidism |
| Q35153078 | Study of beta-cell function (by HOMA model) in metabolic syndrome |
| Q44456380 | Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease |
| Q33594175 | Subjective socioeconomic status and presence of the metabolic syndrome in midlife community volunteers |
| Q27666968 | Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy |
| Q28388533 | Sunflower oil supplementation has proinflammatory effects and does not reverse insulin resistance in obesity induced by high-fat diet in C57BL/6 mice |
| Q34515118 | Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome |
| Q34564212 | Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II |
| Q43167225 | Sweetened beverage consumption and increased risk of metabolic syndrome in Mexican adults. |
| Q88045204 | Syndrome of insulin resistance with acanthosis nigricans, acral hypertrophy and muscle cramps in an adolescent - a rare diagnosis revisited |
| Q53802848 | Synergistic association of changes in serum uric acid and triglycerides with changes in insulin resistance after walking exercise in community-dwelling older women. |
| Q42835466 | Synthesis and biological evaluation of tert-butyl-5-methylpyrimidin-piperazine derivatives as anti-obesity agents |
| Q36036441 | Systemic adaptation of lipid metabolism in response to low- and high-fat diet in Nile tilapia (Oreochromis niloticus) |
| Q34200504 | Systemic inflammation and the metabolic syndrome among middle-aged community volunteers |
| Q35089915 | Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome |
| Q33779657 | Systems genomics of metabolic phenotypes in wild-type Drosophila melanogaster |
| Q94593919 | THE ASSOCIATION BETWEEN PRO AND ANTI-INFLAMMATORY MARKERS WITH THE COMPONENTS OF METABOLIC SYNDROME |
| Q51591547 | Taq1B Polymorphism of Cholesteryl Ester Transfer Protein (CETP) and Its Effects on the Serum Lipid Levels in Metabolic Syndrome Patients. |
| Q34302721 | Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes |
| Q37267253 | Targeting abdominal obesity in cardiology: can we be effective? |
| Q34041538 | Targets for current pharmacologic therapy in cholesterol gallstone disease |
| Q35810322 | Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review |
| Q38634958 | Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism |
| Q36771684 | Testosterone-induced effects on lipids and inflammation |
| Q28395924 | The Association between Shift Work and the Metabolic Syndrome in Female Workers |
| Q40171369 | The Definition and Prevalence of Obesity and Metabolic Syndrome |
| Q64277754 | The Effects of Resveratrol in the Treatment of Metabolic Syndrome |
| Q46356990 | The Efficacy of Acupuncture on Anthropometric Measures and the Biochemical Markers for Metabolic Syndrome: A Randomized Controlled Pilot Study |
| Q33855690 | The Frequency and Risk Factors of Colorectal Adenoma in Health-Check-up Subjects in South Korea: Relationship to Abdominal Obesity and Age. |
| Q55245154 | The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. |
| Q42368235 | The Impact of Sex and 25(OH)D Deficiency on Metabolic Function in Mice. |
| Q40223739 | The Number of Teeth Is Inversely Associated With Metabolic Syndrome: A Korean Nationwide Population-Based Study |
| Q41640666 | The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited |
| Q36234525 | The Prevalence of Metabolic Syndrome According to Different Criteria and its Associated Factors in Type 2 Diabetic Patients in Kerman, Iran |
| Q55332150 | The Prevalence of Obesity and Metabolic Syndrome in the Korean Military Compared with the General Population. |
| Q92406464 | The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome |
| Q36586561 | The Relationship Between Body Mass Index and Bone Mineral Density in Premenopausal and Postmenopausal North Indian Women |
| Q50782992 | The Relationship between Metabolic Syndrome, Its Components, and Dry Eye: A Cross-Sectional Study. |
| Q35944688 | The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men |
| Q89976282 | The Role of High Fat Diets and Liver Peptidase Activity in the Development of Obesity and Insulin Resistance in Wistar Rats |
| Q55050649 | The Role of Insulin Resistance/Hyperinsulinism on the Rising Trend of Thyroid and Adrenal Nodular Disease in the Current Environment. |
| Q61451367 | The Taq1B-variant in the Cholesteryl Ester–Transfer Protein Gene and the Risk of Metabolic Syndrome |
| Q91690326 | The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome |
| Q51350783 | The absence of insulin resistance in metabolic syndrome definition leads to underdiagnosing of metabolic risk in obese patients. |
| Q36062944 | The allosteric modulation of lipases and its possible biological relevance |
| Q38946886 | The association between cytomegalovirus infection, obesity, and metabolic syndrome in U.S. adult females |
| Q46806248 | The association between dietary macronutrient intake and the prevalence of the metabolic syndrome |
| Q35957947 | The association between periodontal disease and metabolic syndrome among outpatients with diabetes in Jordan |
| Q64245557 | The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project |
| Q30365106 | The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis. |
| Q27014777 | The association of periodontitis and metabolic syndrome |
| Q34083999 | The associations between serum zinc levels and metabolic syndrome in the Korean population: findings from the 2010 Korean National Health and Nutrition Examination Survey |
| Q33329737 | The body politic: the relationship between stigma and obesity-associated disease |
| Q36995228 | The caloric restriction paradigm: implications for healthy human aging |
| Q36901530 | The cardiometabolic syndrome and cardiovascular disease |
| Q36929366 | The cardiometabolic syndrome and sarcopenic obesity in older persons |
| Q31164717 | The correlation between waist circumference and ESC cardiovascular risk score: data from the German metabolic and cardiovascular risk project (GEMCAS). |
| Q35696882 | The cross-sectional relationship between dietary calcium intake and metabolic syndrome among men and women aged 40 or older in rural areas of Korea. |
| Q36703033 | The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? |
| Q80159976 | The effect of 4-week chilli supplementation on metabolic and arterial function in humans |
| Q38010557 | The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials |
| Q34264235 | The effect of a lifestyle intervention on metabolic health in young women |
| Q37385685 | The effect of community-based education for lifestyle intervention on the prevalence of metabolic syndrome and its components: tehran lipid and glucose study |
| Q37284155 | The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes In |
| Q35042329 | The effect of family-based multidisciplinary cognitive behavioral treatment in children with obesity: study protocol for a randomized controlled trial |
| Q51463578 | The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis. |
| Q36978268 | The effect of weight loss surgery on the severity of psoriasis |
| Q33552608 | The effectiveness and applicability of different lifestyle interventions for enhancing wellbeing: the study design for a randomized controlled trial for persons with metabolic syndrome risk factors and psychological distress |
| Q38054997 | The effects of acute and chronic stress on diabetes control |
| Q48484033 | The effects of canrenone on inflammatory markers in patients with metabolic syndrome. |
| Q38779222 | The effects of hormones and physical exercise on hippocampal structural plasticity |
| Q36822953 | The emerging genetic landscape underlying cardiac conduction system function |
| Q37889275 | The emerging role of the intestine in metabolic diseases |
| Q46220786 | The endocannabinoid system as a target for obesity treatment |
| Q33696549 | The environment within: how gut microbiota may influence metabolism and body composition |
| Q36749236 | The evolving definitions and increasing prevalence of the metabolic syndrome. |
| Q35137465 | The expression of LEP, LEPR, IGF1 and IL10 in obesity and the relationship with microRNAs. |
| Q24323037 | The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease |
| Q34066395 | The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells. |
| Q57318391 | The growing global burden of dementia |
| Q82194854 | The humoral side of insulin resistance |
| Q51709753 | The impact of ageing on adipose structure, function and vasculature in the B6D2F1 mouse: evidence of significant multisystem dysfunction. |
| Q46845604 | The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes |
| Q35828140 | The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28. |
| Q54456099 | The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL). |
| Q38166061 | The impact of obesity and metabolic syndrome on alcoholic liver disease |
| Q44115081 | The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. |
| Q44951809 | The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study |
| Q33700820 | The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes |
| Q37132923 | The importance of treating cardiometabolic risk factors in patients with type 2 diabetes |
| Q37000746 | The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes |
| Q43230115 | The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk |
| Q47376797 | The influence of body composition, fat distribution, and sustained weight loss on left ventricular mass and geometry in obesity. |
| Q35670421 | The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material |
| Q35054609 | The interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: effect of exercise. |
| Q37367559 | The interplay between inflammation, physical activity and metabolic syndrome in a remote male geriatric community in Southern Taiwan: the Tianliao Old People (TOP) study 03. |
| Q37069016 | The many faces of testosterone. |
| Q35315854 | The mechanism by which moderate alcohol consumption influences coronary heart disease |
| Q53160248 | The metabolic response to a high-fat diet reveals obesity-prone and -resistant phenotypes in mice with distinct mRNA-seq transcriptome profiles. |
| Q33569142 | The metabolic syndrome |
| Q94464808 | The metabolic syndrome |
| Q94464811 | The metabolic syndrome |
| Q35767966 | The metabolic syndrome among patients with cardiovascular disease in Accra, Ghana |
| Q58271154 | The metabolic syndrome and cardiovascular disease |
| Q79751178 | The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort |
| Q36416116 | The metabolic syndrome and its relationship to hypertensive target organ damage |
| Q35586571 | The metabolic syndrome and severity of diabetic retinopathy |
| Q38263577 | The metabolic syndrome and urolithiasis: a systematic review and meta-analysis |
| Q80683625 | The metabolic syndrome as a prohypertensive state |
| Q37691695 | The metabolic syndrome in cancer survivors. |
| Q80515194 | The metabolic syndrome in children and adolescents |
| Q36938565 | The metabolic syndrome in children and adolescents - an IDF consensus report |
| Q42125980 | The metabolic syndrome in patients on peritoneal dialysis: prevalence and influence on cardiovascular morbidity |
| Q36472269 | The metabolic syndrome in polycystic ovary syndrome |
| Q40087419 | The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly |
| Q51483620 | The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. |
| Q36394371 | The metabolic syndrome, hyperlipidemia, and insulin resistance |
| Q29615125 | The metabolic syndrome--a new worldwide definition |
| Q37412702 | The metabolic syndrome: insulin resistance |
| Q33940508 | The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh |
| Q39919146 | The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation |
| Q48043205 | The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice |
| Q33590556 | The prevalence of carotid plaque with different stability and its association with metabolic syndrome in China: The Asymptomatic Polyvascular Abnormalities Community study |
| Q43007154 | The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. |
| Q50914111 | The prevalence of metabolic syndrome and metabolic syndrome risk factors in college-aged students. |
| Q40541325 | The prevalence of metabolic syndrome increases with serum high sensitivity C-reactive protein concentration in individuals without a history of cardiovascular disease: a report from a large Persian cohort. |
| Q102152316 | The prevalence of pediatric metabolic syndrome-a critical look on the discrepancies between definitions and its clinical importance |
| Q37040892 | The prevalence of the metabolic syndrome in Korean children and adolescents: comparisons of the criteria of Cook et al., Cruz and Goran, and ferranti et al |
| Q55546765 | The prognostic significance of metabolic syndrome and weight loss in esophageal squamous cell carcinoma. |
| Q28583489 | The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model |
| Q37423513 | The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis |
| Q27003277 | The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance |
| Q30100978 | The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance |
| Q91979476 | The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: A prospective observational study |
| Q35051207 | The relationship between body size and mortality in the linked Scottish Health Surveys: cross-sectional surveys with follow-up. |
| Q44531169 | The relationship between childhood parental loss and metabolic syndrome in obese subjects |
| Q89785818 | The relationship between metabolic syndrome and the incidence of colorectal cancer |
| Q38204071 | The relationship between obesity and coronary artery disease |
| Q37478675 | The relationship between physical activity levels and metabolic syndrome in male white-collar workers |
| Q37081244 | The relationship between school performance and the number of physical education classes attended by korean adolescent students |
| Q49391011 | The relationship of alanine aminotransferase to metabolic syndrome in a Korean population. |
| Q38321150 | The relationship of breakfast skipping and type of breakfast consumed with overweight/obesity, abdominal obesity, other cardiometabolic risk factors and the metabolic syndrome in young adults. The National Health and Nutrition Examination Survey (NH |
| Q35688755 | The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome |
| Q44789248 | The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the NEO study |
| Q35036116 | The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies |
| Q38921695 | The role of insufficient copper in lipid synthesis and fatty-liver disease |
| Q33804391 | The role of interleukin-18 in the metabolic syndrome |
| Q37680486 | The role of isovolumic acceleration in predicting subclinical right and left ventricular systolic dysfunction in patient with metabolic syndrome |
| Q43179081 | The role of physical activity and fitness on the metabolic syndrome in adolescents: effect of different scores. The AFINOS Study |
| Q36709546 | The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? |
| Q100694481 | The role of stress kinases in metabolic disease |
| Q34097510 | The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. |
| Q53696647 | The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review. |
| Q47882490 | The role of the circadian clock system in physiology |
| Q46178863 | The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans. |
| Q37370220 | The sasang constitution as an independent risk factor for metabolic syndrome: propensity matching analysis |
| Q64243955 | The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome |
| Q36892498 | The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease |
| Q40009175 | The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men's Health Study). |
| Q99564753 | The triterpenoid sapogenin (2α-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR/GLP-1 axis through gut microbiota remodelling |
| Q21093273 | The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome |
| Q37635748 | The utility of physical activity in the management of global cardiometabolic risk |
| Q36752075 | Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach |
| Q35753018 | Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome |
| Q37585546 | Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance |
| Q37825945 | Therapies for diabetic dyslipidaemia |
| Q35948819 | Therapy of gallstone disease: What it was, what it is, what it will be |
| Q51387044 | Thin newborns are more insulin resistant at 10 years of age. |
| Q35308245 | Three clustering patterns among metabolic syndrome risk factors and their associations with dietary factors in Korean adolescents: based on the Korea National Health and Nutrition Examination Survey of 2007-2010. |
| Q36252132 | Thylakoids reduce body fat and fat cell size by binding to dietary fat making it less available for absorption in high-fat fed mice |
| Q36109823 | Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials |
| Q35644219 | Tonsilectomy in sickle cell diseases. |
| Q51289731 | Tooth loss and metabolic syndrome in middle-aged Japanese adults. |
| Q28236480 | Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial |
| Q34255878 | Toward a unifying hypothesis of metabolic syndrome. |
| Q89207836 | Trace proteinuria by dipstick screening is associated with metabolic syndrome, hypertension, and diabetes |
| Q53553914 | Transcriptomic characterization of the long-term dihydrotestosterone effects in adipose tissue. |
| Q36225931 | Transgenerational inheritance of metabolic disease |
| Q91638348 | Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency |
| Q46872374 | Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. |
| Q38503454 | Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans. |
| Q36806514 | Treating insulin resistance: future prospects. |
| Q43233636 | Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort |
| Q36815978 | Treating the metabolic syndrome. |
| Q36300178 | Treatment of dyslipidemia in children and adolescents |
| Q37505539 | Treatment of hypertension in metabolic syndrome: implications of recent clinical trials. |
| Q36411221 | Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway |
| Q30277280 | Trends in Metabolic Syndrome Severity and Lifestyle Factors Among Adolescents |
| Q46052844 | Trends in the prevalence of abdominal obesity and overweight in English adults (1993-2008). |
| Q36825147 | Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation |
| Q47574386 | Triglyceride to high density lipoprotein cholesterol ratio and its association with periodontal disease in Korean adults: findings based on the 2012-2014 Korean national health and nutrition examination survey. |
| Q43216549 | Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. |
| Q35120360 | Triglycerides and heart disease: still a hypothesis? |
| Q47745963 | Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance |
| Q30352122 | Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes? |
| Q46035597 | Two weeks of overfeeding with candy, but not peanuts, increases insulin levels and body weight. |
| Q43595131 | UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity |
| Q80058425 | Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women |
| Q35866336 | Unacylated Ghrelin is associated with the isolated low HDL-cholesterol obese phenotype independently of insulin resistance and CRP level |
| Q35231861 | Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases |
| Q57268336 | Understanding the complexity of glycaemic health: systematic bio-psychosocial modelling of fasting glucose in middle-age adults; a DynaHEALTH study |
| Q21245293 | Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile |
| Q64118050 | Unfavorable Associations Between Serum Trimethylamine N-Oxide and L-Carnitine Levels With Components of Metabolic Syndrome in the Newfoundland Population |
| Q35707639 | Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik) |
| Q34461400 | Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndrome |
| Q44875192 | Upregulation of skeletal muscle inflammatory genes links inflammation with insulin resistance in women with the metabolic syndrome. |
| Q26850727 | Uric acid, hyperuricemia and vascular diseases |
| Q34639560 | Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome |
| Q43060743 | Urodynamic effects of once-daily tadalafil in men with LUTS secondary to clinical BPH. |
| Q51895865 | Use of anthropometric measures to predict insulin resistance. |
| Q58544745 | Use of various obesity measurement and classification methods in occupational safety and health research: a systematic review of the literature |
| Q36923620 | Using a novel coculture model to dissect the role of intramuscular lipid load on skeletal muscle insulin responsiveness under reduced estrogen conditions |
| Q34581577 | Utility of obesity indicators for metabolically healthy obesity: an observational study using the Korean National Health and Nutrition Examination Survey (2009-2010). |
| Q46122309 | Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats |
| Q34074813 | Validation of metabolic syndrome using medical records in the SUN cohort |
| Q50694806 | Validation, Identification, and Biological Consequences of the Site-specific O-GlcNAcylation Dynamics of Carbohydrate-responsive Element-binding Protein (ChREBP). |
| Q33440635 | Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits |
| Q51372103 | Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome. |
| Q46174250 | Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression |
| Q35106315 | Vascular biology of metabolic syndrome |
| Q51765296 | Vascular risk factors for male and female urgency urinary incontinence at age 68 years from a British birth cohort study. |
| Q46970579 | Visceral fat is correlated with prolonged operative time in laparoendoscopic single-site adrenalectomy and laparoscopic adrenalectomy |
| Q46194979 | Visceral fat predominance is associated with non-alcoholic fatty liver disease in Japanese women with metabolic syndrome |
| Q47699313 | Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy. |
| Q35001920 | Vitamin C restores healthy aging in a mouse model for Werner syndrome |
| Q36945189 | Vitamin D Status Is Associated with Metabolic Syndrome in a Clinic-Based Sample of Hispanic Adults |
| Q34461729 | Vitamin D status and cardiometabolic risk factors in the United States adolescent population |
| Q37397439 | Vitamin D status and its association with cardiometabolic risk factors in Korean adults based on a 2008-2010 Korean National Health and Nutrition Examination Survey |
| Q37953480 | Vitamin d and metabolic syndrome risk factors: evidence and mechanisms |
| Q46036413 | Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. |
| Q57114523 | Waist Circumference Coupled with Either HDL-C or TG Can Be Used as a Diagnostic Marker for Metabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome |
| Q34373025 | Waist circumference a good indicator of future risk for type 2 diabetes and cardiovascular disease |
| Q33399288 | Waist circumference and insulin resistance: a cross-sectional study of Japanese men. |
| Q35312593 | Waist circumference and risk of lower urinary tract symptoms: a meta-analysis |
| Q47231132 | Waist circumference to assess reversal of insulin resistance following weight reduction after bariatric surgery: cohort and cross-sectional studies |
| Q34338396 | Waist-to-hip ratio, dyslipidemia, glycemic levels, blood pressure and depressive symptoms among diabetic and non-diabetic Chinese women: a cross-sectional study |
| Q47169055 | Water T2 as an early, global and practical biomarker for metabolic syndrome: an observational cross-sectional study |
| Q45986273 | Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats. |
| Q34503739 | Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action |
| Q27687558 | Weight control and prevention of metabolic syndrome by green tea. |
| Q40935538 | Weight gain and hypertension at three years of age and older in extremely low birth weight infants |
| Q30572730 | Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? |
| Q37606193 | Weight loss before a diagnosis of type 2 diabetes mellitus is a risk factor for diabetes complications |
| Q47412338 | Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome |
| Q34686210 | Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study |
| Q52569936 | What is the evidence for a role for diet and nutrition in osteoarthritis? |
| Q59650494 | What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects? |
| Q35073216 | Whole blood gene expression profiles in insulin resistant Latinos with the metabolic syndrome |
| Q37378541 | Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. |
| Q38067362 | Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? |
| Q61807097 | Wnt Pathway Inhibitor DKK1: A Potential Novel Biomarker for Adiposity |
| Q46267177 | Women are at a higher risk of metabolic syndrome in rural Malaysia. |
| Q28078499 | Women in Saudi Arabia and the Prevalence of Cardiovascular Risk Factors: A Systematic Review |
| Q36739152 | Women's health and the metabolic syndrome |
| Q51244848 | Xylobiose Prevents High-Fat Diet Induced Mice Obesity by Suppressing Mesenteric Fat Deposition and Metabolic Dysregulation. |
| Q34538128 | Yoga for metabolic syndrome: A systematic review and meta-analysis |
| Q82050652 | [A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results] |
| Q81792470 | [Bipolar disorder and somatic comorbidity] |
| Q82067297 | [Comorbidities and complications of adiposis] |
| Q84279858 | [Comorbidities in psoriasis] |
| Q52297905 | [Depression and health state]. |
| Q51366651 | [Evaluation of the intake of a low daily amount of soybeans in oxidative stress, lipid and inflammatory profile, and insulin resistance in patients with metabolic syndrome]. |
| Q64971376 | [Laparoscopic gastric banding--where are the limits?]. |
| Q94501996 | [Metabolic syndrome] |
| Q81415779 | [Steatosis during chronic hepatitis C: the role of insulin resistance and viral factors] |
| Q42058768 | c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice |
| Q51765298 | n-3 PUFA prevent metabolic disturbances associated with obesity and improve endothelial function in golden Syrian hamsters fed with a high-fat diet. |
| Q57812685 | ¹H NMR Spectroscopy and MVA to Evaluate the Effects of Caulerpin-Based Diet on Lipid Profiles |
| Q37551918 | β-Adrenergic Receptor and Insulin Resistance in the Heart |
| Q34620434 | β-cell function is associated with metabolic syndrome in Mexican subjects |
Search more.